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Abstract 
 
Muscles of aged individuals display high susceptibility to injury and impaired 
regeneration. Developing strategies to restrict damage or enhance repair for older 
individuals requires a mechanistic understanding of both the damage and repair 
processes following injury and the impact of aging on those processes. The overall 
objective of this dissertation was to address fundamental gaps in our knowledge of 
cellular and molecular events associated with a common form of muscle injury and to 
identify age-related changes in key events. We conducted experiments using 
established models of lengthening contraction-induced injury in young and old mice. We 
first pursued the question of whether reactive oxygen species (ROS) generated during 
damaging lengthening contractions contribute to the initiation of the injury. We found 
that lengthening contractions did not generate more ROS than non-damaging isometric 
contractions, arguing against ROS as an initiating factor in the injury process. Because 
neutrophils exacerbate muscle damage while macrophages contribute to repair, we next 
investigated molecular mechanisms of neutrophil migration into injured muscle and the 
associations between myeloid cell levels and muscle degeneration and regeneration in 
old animals. Treatment with blocking antibodies for P- and E-selectin reduced neutrophil 
levels in injured muscles by half, supporting the importance of these molecules for 
neutrophil accumulation after lengthening contractions. Despite 50% fewer neutrophils, 
no reduction in damage was observed, indicating no direct relationship between 
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neutrophil levels and injury. Moreover, 30-50% more neutrophils in muscles of old 
compared with adult mice was not associated with more severe injury. Despite more 
neutrophils, impaired regeneration in muscles of old mice was not associated with an 
inability to clear these cells nor impaired recruitment of macrophages with age. Indeed, 
for a given level of muscle injury in old mice, we found 20-50% more macrophages, 
including anti-inflammatory macrophages. Muscles of old mice also showed aberrant 
expression of macrophage-associated inflammatory mediators including tumor necrosis 
factor-alpha and interleukin-10, which have the potential to undermine muscle 
regeneration. In summary, our studies do not support antioxidant or anti-P/E-selectin 
therapies to mitigate damage in older individuals. Instead, targeting specific myeloid cell 
functions may represent a superior therapeutic approach. 
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Chapter 1 
 
Introduction  
 
Motivation 
 
Age-related declines in skeletal muscle 
 Aging is associated with progressive declines in skeletal muscle mass and 
function (1). Studies comparing men and women between the ages of 40 and 80 years 
have shown a 30-50% decrease in muscle mass and at least an equal but usually even 
greater decrease in strength in older individuals (2). Muscle power (force x velocity) also 
decreases with age. Studies comparing healthy subjects in the 20-40 year age range to 
healthy subjects in the 70-80 year age range have demonstrated 20-40% declines in 
muscle power in older individuals (3). The age-related loss of muscle mass is attributed, 
at least in part, to a loss of muscle fibers as well as a decrease in size (i.e. cross-
sectional area) of the remaining fibers (3, 4). There is particularly a loss of type II (fast 
twitch) fibers, which contribute to the loss of muscle power (3). The decrease in strength 
is attributed to the decrease in muscle mass (4), as force generation is proportional to 
cross-sectional muscle area (5). However, decreases in strength are still observed after 
normalizing strength to the cross-sectional muscle area, suggesting the remaining 
muscle from older individuals is intrinsically weaker (3). This decline in muscle quality 
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may be due in part to age-related changes in muscle composition, as muscles from 
older individuals contain more fat and connective tissue (3, 4).  
 The age-related declines in muscle mass, strength, power and quality can have 
serious consequences for older individuals. Impaired muscle strength and muscle fat 
infiltration are predictors of impaired mobility, defined as difficulty walking or climbing 
stairs (6), and impaired muscle strength, especially in the lower extremities, is a risk 
factor for falls and associated fractures (7). The loss of muscle mass increases the risk 
of developing physical disability, defined as difficulty performing the activities of daily 
living (8). Thus, age-related muscle declines can significantly impact quality of life and 
limit independence in older individuals, as well as contribute to the need for residential 
care and associated health care costs.  
 
Causes of age-related declines in skeletal muscle 
Age-related declines in muscle mass, function, and quality are likely due to many 
contributing factors, and many have been proposed, including muscle fiber denervation 
and the loss or remodeling of motor units, changes in protein metabolism, changes in 
the endocrine milieu, increased systemic inflammation, and increased oxidative stress, 
to name a few (2, 3, 9-12). 
Also proposed as a contributing factor is the response of aged muscle to certain 
activities that can cause muscle damage (10, 11, 13). Muscles of aged individuals are 
more susceptible to damage following certain types of exercise or contractions (14-17). 
Muscles from aged individuals also have a diminished ability for repair, as shown by 
slowed recovery of strength (18) and increased fat accumulation (19). Cycles of 
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frequent damage followed by incomplete repair may be an important contributing factor 
to the progressive losses of muscle mass and function that occur with aging. 
Therefore, restricting damage or enhancing repair after muscle injury is a 
worthwhile goal for the benefit of older individuals. Developing strategies to restrict 
damage or enhance repair requires a mechanistic understanding of both the damage 
and repair processes following injury as well as an understanding of the mechanisms 
underlying the age-related increase in susceptibility to damage and impaired repair.  
 
Background 
 
Causes of skeletal muscle injury 
Skeletal muscle injuries are extremely common. Muscle constitutes a large 
proportion of the body and many muscles have superficial locations, rendering them 
susceptible to injuries caused by physical insults (e.g. lacerations, contusions, puncture 
wounds, crush injuries), extreme temperatures (e.g. freeze injuries, burns) or invasive 
surgery. Muscles can also be injured by toxins (e.g. snake venoms), periods of 
unloading followed by reloading, and periods of ischemia followed by reperfusion. 
Finally, muscles can also be injured by their own contractions. Injuries caused by 
contractions are probably the most common injuries experienced by skeletal muscle.  
Muscle is especially susceptible to injury during lengthening (or eccentric) 
contractions (20). Lengthening contractions occur when muscles are stretched while 
activated and injuries caused by lengthening contractions are referred to as contraction-
induced injuries. Lengthening contractions occur during normal, everyday movements, 
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such as lowering oneself into a chair, walking down a flight of stairs, or lowering a heavy 
package onto a table. Certain activities, such as downhill running, involve repetitive 
lengthening contractions. Repetitive lengthening contractions, especially when muscles 
are unaccustomed to such movements, often produce injury and associated symptoms 
of soreness, swelling, decreased range of motion and loss of strength (21). 
Alternatively, even a single lengthening contraction can produce injury, perhaps during 
an accidental fall, especially if the stretch is severe and the muscle is maximally 
activated (2). 
 
Repair process following skeletal muscle injury 
Contraction-induced muscle injury and repair are similar in humans and animals 
(i.e. rodents and rabbits) and an extensive series of studies from these species has 
contributed to our understanding of the injury and repair process. Most of the events 
described in the following paragraphs are from studies in which the injury was initiated 
by lengthening contractions or eccentric exercise. However, it should be noted that 
regardless of the nature of the initial insult, injured muscles generally go though similar 
sequential but overlapping stages of degeneration, inflammation and necrosis followed 
by regeneration and remodeling. 
Lengthening contractions produce immediate disruptions in skeletal muscle (22). 
Within minutes of lengthening contractions, ultrastructural damage to contractile 
proteins and sarcomeres is evident within muscle fibers (23-25), as well as disruption of 
components of the cytoskeleton involved in force transmission (26, 27). There is 
evidence of damage to the muscle cell membrane (27) and impaired excitation-
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contraction coupling, perhaps from damage to T-tubules and the sarcoplasmic reticulum 
(28). The immediate damage is accompanied by an impaired ability to generate force 
(i.e. a force deficit) (25, 29). 
The degenerative stage of muscle injury occurs within hours after lengthening 
contractions and lasts for several days. Calcium moves down its concentration gradient 
into the muscle cell cytoplasm, possibly through damage to the cell or sarcoplasmic 
reticulum membranes (22). Increased intracellular calcium causes hypercontractions of 
portions of muscle fibers, which are visible as large, swollen fibers in transverse muscle 
sections and leave adjacent portions of the same fibers barely visible or missing (24, 
30). Increased intracellular calcium can also activate the calpains, proteolytic enzymes 
that initiate the breakdown of myofibrils and cytoskeletal elements (31). Degenerating 
and necrotic fibers are visible in transverse muscle sections (29), and a loss of muscle 
fibers is observed along with an increased or maintained force deficit (13, 29, 32). 
Repair and regeneration begin within the first week and the regenerative stage 
can last for a few weeks. Successful muscle regeneration relies on muscle stem cells 
known as satellite cells, named for their location at the periphery of mature muscle 
fibers. In response to injury, satellite cells exit their normal quiescent state, proliferate, 
and migrate to the site of injury. These cells then differentiate and fuse together to form 
new myofibers or fuse to existing fibers to repair damage (33, 34). Repaired and 
regenerating muscle fibers are identified by their centrally located nuclei. Early in the 
regeneration process, new myofibers are visible as small basophilic centronucleated 
myofibers, which increase in size over time (35). Finally, a remodeling stage occurs, 
characterized by extracellular matrix production and remodeling, and angiogenesis (36). 
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Accompanying the degenerative and regenerative phases is the accumulation of 
myeloid cells (i.e. neutrophils and macrophages) (37). Neutrophils are the first to 
increase in number in injured muscle, arriving from the circulation within hours of the 
initial insult. Neutrophil levels peak within 1-2 days following the initial insult and then 
their numbers decline to control levels within 7 days after the injury (38). Following the 
arrival of neutrophils, macrophages begin to accumulate in injured muscle. Pro- and 
anti-inflammatory macrophages are observed. Early arriving, pro-inflammatory 
macrophages invade muscle fibers and are associated with the removal of damaged 
and necrotic tissue (39-41). Pro-inflammatory macrophage numbers decline within a few 
days as the number of anti-inflammatory macrophages increases. Anti-inflammatory 
macrophages can remain in the muscle for many days and their presence generally 
coincides with the regenerative stage of muscle repair (39-41). 
Ultimately, in young and healthy muscles, the injured muscles return to a state 
not detectably different from muscles that were never injured. 
 
Dissertation objectives and overview of chapters 
 
Dissertation objectives 
Although much is known about the sequence of events following muscle injury, 
the underlying cellular and molecular mechanisms remain incompletely understood. 
Furthermore, the mechanisms underlying the age-related increase in susceptibility to 
damage and delayed or incomplete repair are not well understood. Understanding these 
mechanisms may reveal key therapeutic targets for restricting damage or enhancing 
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repair for individuals whose muscles do not fully recover after injury due to advanced 
age. 
Therefore, the overall objectives of this research were 1) to address fundamental 
gaps in our knowledge of cellular and molecular events associated with a common form 
of muscle injury and 2) to identify age-related changes in key events.  
 
Overview of dissertation chapters 
Early initiators of degenerative and regenerative processes following contraction-
induced injury have not been clearly defined. ROS generated during lengthening 
contractions may contribute to degenerative or regenerative processes, as ROS can 
cause direct damage to macromolecules (42) and ROS signaling can affect many 
processes that contribute to degeneration or regeneration following injury (43, 44). 
Furthermore, age-related changes in damage and repair are accompanied by aberrant 
ROS homeostasis (45, 46) and at least one study suggests that ROS production around 
the time of injury enhances initial damage in old animals (47). Chapter 2 describes 
published work (48) that examines whether ROS generated at the time of injury are an 
early initiator of downstream processes of degeneration and regeneration.  
Despite accumulating evidence that the number of myeloid cells present in 
injured muscle is a critical factor in the success of muscle repair (32, 49-53), the effect 
of aging on the magnitude and the timing of the myeloid cell response to injury has 
received little attention. Chapter 3 explores age-related changes in the magnitude of the 
myeloid cell response to injury and examines whether such changes correlate with 
impaired regeneration in aged animals. 
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Given the critical role of myeloid cells in determining the success or failure of 
muscle repair, manipulating myeloid cell infiltration after contraction-induced injury may 
be an effective strategy for either preventing damage or enhancing repair in aged 
populations. Neutrophils can exacerbate damage to muscle fibers following injury while 
macrophages generally contribute to repair (32, 50-53). Thus, preventing or blunting the 
neutrophil response while keeping the macrophage response intact may provide a 
therapeutic benefit. However, the molecules responsible for neutrophil infiltration after 
contraction-induced injury are not entirely known. Potential candidates are P- and E-
selectin proteins that are expressed on the luminal surface of blood vessels and interact 
with corresponding ligands on neutrophils. The selectins mediate initial steps in a well-
characterized cascade that culminates with neutrophil migration out of the blood vessel 
and into the surrounding tissue, at least under some circumstances (54). Chapter 4 
investigates the role of P- and E-selectin molecules in neutrophil and macrophage 
accumulation after muscle injury and examines whether blunting neutrophil 
accumulation by blocking the selectins provides a therapeutic benefit. The findings in 
Chapter 4 also help to interpret findings from Chapter 3. 
Mouse models were used for all experiments. Rodents demonstrate many of the 
age-related changes observed in muscle, including reductions in muscle mass and 
force generation (55-57), increased susceptibility to damage following contractions (47, 
58, 59), and delayed or incomplete repair (56, 60-64). Experiments were conducted 
using well-established in vitro (65, 66) and in situ injury models (25, 29, 32, 47, 56, 57, 
63, 67). 
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Chapter 2 
 
Reactive oxygen species generation is not different during isometric and 
lengthening contractions of mouse muscle 
 
Abstract 
 
Skeletal muscles can be injured by lengthening contractions, when the muscles 
are stretched while activated. Lengthening contractions produce structural damage that 
leads to the degeneration and regeneration of damaged muscle fibers by mechanisms 
that have not been fully elucidated. Reactive oxygen species (ROS) generated at the 
time of injury may initiate degenerative or regenerative processes. In the present study 
we hypothesized that lengthening contractions that damage the muscle would generate 
more ROS than isometric contractions that do not cause damage. To test our 
hypothesis, we subjected muscles of mice to lengthening contractions or isometric 
contractions and simultaneously monitored intracellular ROS generation with the 
fluorescent indicator 5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescein (CM-
DCFH), which is oxidized by ROS to form the fluorescent product CM-DCF. We found 
that CM-DCF fluorescence was not different during or shortly after lengthening 
contractions compared with isometric controls, regardless of the amount of stretch and 
damage that occurred during the lengthening contractions. The only exception was that 
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after severe stretches, the increase in CM-DCF fluorescence was impaired. We 
conclude that lengthening contractions that damage the muscle do not generate more 
ROS than isometric contractions that do not cause damage. The implication is that ROS 
generated at the time of injury are not the initiating signals for subsequent degenerative 
or regenerative processes. 
 
Introduction 
 
Skeletal muscles can be injured by lengthening contractions, when the muscles 
are stretched while activated. Lengthening contractions produce immediate 
ultrastructural damage within muscle fibers, and the damage is accompanied by a 
deficit in force generation. In the hours, days, and weeks following the initial injury, 
inflammatory cells invade the tissue and muscle fibers undergo a process of 
degeneration, necrosis, and regeneration (1). The cellular and molecular mechanisms 
by which the initial injury initiates degenerative and regenerative processes remain 
incompletely understood. Understanding these mechanisms may reveal key therapeutic 
targets for restricting degeneration or enhancing regeneration for individuals whose 
muscles do not fully recover after injury due to advanced age (2, 3), disease (4-6), or 
severe trauma (7).  
Reactive oxygen species (ROS) generated at the time of initial injury may 
contribute to degenerative or regenerative processes. ROS can cause direct damage to 
macromolecules, including proteins and lipids (8) or act indirectly via a wide variety of 
pathways to influence gene transcription and expression (9, 10). In muscle, ROS 
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signaling is thought to affect many processes that could contribute to degeneration or 
regeneration following injury, including protein degradation, autophagy, cell death, 
inflammation, cell proliferation, cell differentiation, and mitochondrial biogenesis (11, 
12). Despite the potential involvement of ROS or ROS signaling in degenerative or 
regenerative processes following the initial injury, ROS generation at the time of the 
initial injury has not been studied. Therefore, the main objective of our study was to 
examine ROS generation at the time of the initial injury, during lengthening contractions 
that damage the muscle.  
Our expectation that lengthening contractions would generate ROS is supported 
by reports of increased ROS production within skeletal muscle fibers during contractions 
(13-17). Contraction-induced ROS generation has been attributed to non-mitochondrial 
sources (18,19) and specifically, NADPH oxidase has been implicated (20, 21). ROS 
production has also been reported during passive stretches of skeletal muscle fibers 
and cardiac myocytes (22-24). Although ROS production during passive stretches is not 
a universal finding (23, 25), it is conceivable that lengthening contractions that involve 
both stretch and activation generate more ROS than during activation alone. 
Accordingly, we hypothesized that damaging lengthening contractions would generate 
more ROS than isometric contractions that do not cause damage. To test the 
hypothesis, we subjected muscles of mice to lengthening contractions (LC) or isometric 
contractions (IC) and simultaneously monitored intracellular ROS generation with the 
fluorescent indicator 5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein (CM-
DCFH), which is oxidized by ROS to form the fluorescent product CM-DCF. Passive 
stretches (PS), i.e. stretches without activation, were also administered to examine the 
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degree to which increased CM-DCF fluorescence during lengthening contractions may 
represent an additive effect of ROS generation during stretch plus ROS generation 
during muscle activation.  
 
Methods 
 
Animals.  Male C57BL/6J mice, 7-9 mo of age (retired breeders), were 
purchased from the Jackson Laboratory and housed in a specific-pathogen-free facility 
at the University of Michigan. The mice weighed 32 ± 3 g (mean ± SD, N = 59). On the 
day of an experiment, a mouse was anesthetized with an intraperitoneal injection of 
Avertin (tribromoethanol, 250 mg/kg) (chemical components from Sigma-Aldrich, St. 
Louis, MO). After the mouse was unresponsive to tactile stimuli, one forepaw was 
removed and the mouse was euthanized with an overdose of Avertin followed by 
induction of a bilateral pneumothorax. All animal use procedures were approved by the 
University of Michigan Committee on the Use and Care of Animals (UCUCA). 
Lumbrical muscle preparation. All experiments were conducted in vitro using 
forepaw lumbrical (LMB) muscles. The extremely small LMB muscle offers the diffusion 
benefits of an isolated single fiber while providing a model of whole muscle with intact 
extracellular matrix and tendons (26). The forepaw was pinned in a shallow dish filled 
with Tyrode “dissection” solution composed of (in mM): 136.5 NaCl, 11.9 NaHCO3, 5.0 
KCl, 1.8 CaCl2, 0.5 MgCl2, 0.4 NaH2PO4, and 0.1 EDTA. A whole LMB muscle was 
dissected free from the third digit relative to the medial side of the paw and cleaned of 
as much connective tissue as possible to facilitate subsequent visualization of fiber 
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striations. Monofilament nylon suture (USP 10/0, Ashaway Line & Twine) was used to 
tie the LMB muscle into an experimental chamber, with the proximal tendon attached to 
a high-speed length controller (318B, Aurora Scientific) and the distal tendon attached 
to a force transducer (400A, Aurora Scientific). Ties were placed as close to muscle 
fibers as possible to minimize effects of tendon compliance. The chamber was perfused 
with Tyrode “experiment” solution (in mM): 121 NaCl, 24 NaHCO3, 5.5 glucose, 5.0 KCl, 
1.8 CaCl2, 0.5 MgCl2, 0.4 NaH2PO4, and 0.1 EDTA. Tyrode solutions were made with 
chemicals purchased from Sigma-Aldrich. The solution was bubbled with 95% O2-5% 
CO2 to maintain a pH of 7.3. The temperature of the solution was maintained at 25 °C. 
The chamber was placed on the stage of an inverted microscope (Axiovert 100, 
Carl Zeiss Microscopy) and fiber striations were visible through the transparent bottom 
of the chamber. A video sarcomere length system (900B-5A, Aurora Scientific) 
monitored striation spacing and reported sarcomere length. For all muscles, fiber length 
(Lf) was calculated as previously described (27). Because LMB fibers are arranged 
parallel to the long axis of the muscle, the number of sarcomeres in series within a fiber 
can be inferred by changing the muscle length by a known amount and measuring the 
resulting change in sarcomere length. The number of sarcomeres in series is then 
multiplied by 2.5 µm to calculate fiber length. After the fiber length was calculated, the 
length of the muscle was adjusted until the sarcomere length was 2.5 µm (i.e. optimal 
length).  
CM-DCF fluorescence measurements. A rectangular aperture with adjustable 
dimensions was placed in the image path between the muscle and the photodetector, 
allowing selection of the image area from which fluorescence measurements were 
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obtained. The aperture was adjusted to select a region of the muscle image that was 
0.12 mm x 0.60 mm, equivalent to approximately 12% of the area occupied by the 
image. Fluorescence was elicited by light originating from a 75 W xenon lamp. A 
diffraction grating monochromator (Deltascan 4000, Photon Technology International) 
was used to select excitation wavelengths centered at 493 nm (bandwidth 2 nm). The 
excitation light was reflected through an angle of 90° by a dichroic mirror and passed 
through the microscope objective before reaching the muscle. The emitted fluorescence 
was collected by the objective and passed through the dichroic mirror and a band-pass 
filter (535 ± 20 nm) and detected using a photomultiplier detection system (814, Photon 
Technology International). The dichroic mirror reflected wavelengths shorter than 505 
nm and passed those longer than 505 nm. Fluorescence was measured before loading 
any indicator to determine background fluorescence. 
Loading of CM-DCFH and measuring CM-DCF fluorescence were performed at 
25 °C and experiments were conducted in a darkened laboratory room to minimize 
photobleaching of the indicator and contaminating room light from reaching the 
photodetector. CM-H2DCF-DA (C6827, Life Technologies, Carlsbad, CA) was dissolved 
in ethanol and combined with Tyrode dissection solution containing 0.1% (v/v) Pluronic 
F-127 (P-6866, Life Technologies) to facilitate suspension of CM-H2DCF-DA. The final 
concentration of the CM-H2DCF-DA solution was 15 µM. The CM-H2DCF-DA solution 
was added to the chamber and 30 min were allowed for passive diffusion of CM-
H2DCF-DA into muscle fibers and conversion to the retained form, CM-DCFH, by 
intracellular esterases. After 30 min, the chamber was perfused with Tyrodes 
experiment solution for 5 min to remove residual CM-H2DCF-DA. Perfusion with 
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Tyrodes experiment solution continued during the CM-DCF measurements. CM-DCF 
fluorescence was monitored continuously (10 samples/s) for 3 min before the onset of 
IC, LC, or PS to establish a baseline. CM-DCF fluorescence was then monitored during 
IC, LC, or PS, and for 5 min afterward. Muscles remained in the dark for 5 more min 
before the final isometric contraction was elicited (see Isometric contractions).  
Preliminary experiments suggested that 15 µM of CM-H2DCF-DA was more than 
sufficient for our study. When hydrogen peroxide was added to the chamber after a 
typical experiment, the DCF fluorescence increased by as much as 15-fold, indicating 
that only a small portion of the probe was oxidized during any given experiment and that 
our ability to detect ROS was not limited by a shortage of unoxidized probe within the 
muscle.  
Isometric contractions. Muscle activation was accomplished by electric field 
stimulation via platinum plate electrodes. Stimulus pulses were 0.2 ms in duration and 
the stimulation current was adjusted in order to elicit maximum twitch force. The muscle 
was subjected to a single isometric contraction to establish “pre-protocol force”. After 
the muscle was loaded with CM-DCFH, the muscle was subjected to a protocol of 12 
isometric tetanic contractions spaced 8 s apart. Each tetanus was 400 ms in duration, 
and the stimulus pulses within each tetanus were delivered at a rate of 200 s-1. Force 
was recorded continuously throughout the contraction protocol. A single isometric 
tetanus was elicited 10 minutes after the 12th contraction to assess the deficit in 
isometric force in the absence of fatigue. Force deficit was calculated by the following 
equation: Force deficit (%) = [(pre-protocol force – force 10 min after protocol)/(pre-
protocol force)] X 100.  
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Lengthening contractions and passive stretches. Muscles exposed to LC were 
treated the same as muscles exposed to IC, except that a stretch was initiated at the 
beginning of the 400 ms stimulation period. Muscles were lengthened at the appropriate 
rate to cause the peak of the stretch to coincide with the end of the tetanic stimulation. 
In one series of experiments, muscles were stretched by 40% Lf at a rate of 1 Lf/s, and 
in a second series of experiments, muscles were stretched by 10, 30, or 50% Lf at rates 
of 0.25, 0.75, or 1.25 Lf/s, respectively.  Muscles exposed to PS were treated the same 
as muscles exposed to LC, except that the muscles were not activated.  
Large strains relative to fiber length were chosen to ensure that muscles would 
be damaged during lengthening contractions (28). Strains as large as 30-50% relative to 
fascicle length (an estimate of fiber length) have been reported in vivo for human 
gastrocnemius muscles during dorsiflexion (29, 30) and vastus lateralis muscles during 
knee flexion (31). Modeling studies incorporating subject data have also found that 
fascicles actively lengthened as much as 37% (splenius capitis) and 50% (semispinalis 
capitis) during low-velocity automobile impacts (32), and 64% near the myotendinous 
junction of the biceps femoris muscle (33). Similar strains have been reported for 
passive stretches of biceps femoris and gastrocnemius muscle (29, 30, 34). LMB 
muscles likely do not experience large strains in vivo, but can be considered models for 
other muscles. 
Isometric contractions after lengthening contractions. For some LMB muscles, a 
series of IC was elicited 10 min after the 12th lengthening contraction, according to the 
activation protocol described above for Isometric contractions. During the intervening 10 
min, no additional CM-H2DCF-DA was added to the chamber. CM-DCF fluorescence 
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was collected for 2 min before the onset of IC to re-establish baseline oxidation and 
CM-DCF fluorescence monitoring continued during the series of IC.  
GSHEE experiments. In order to confirm that CM-DCF fluorescence was 
sensitive to intracellular changes in ROS, ROS generation was measured in the 
presence of glutathione reduced ethyl ester (GSHEE). LMB muscles were prepared and 
tested as previously described with the following exceptions. After the pre-protocol force 
was measured, dissection solution containing 2.5 mM glutathione reduced ethyl ester 
(GSHEE) (G1404, Sigma-Aldrich) was added to the chamber. LMB muscles were 
exposed to GSHEE for 1 hr before exposure to 15 µM CM-H2DCF-DA solution for 30 
min. To remove residual CM-H2DCF-DA, fresh dissection solution was added to the 
chamber before isometric contractions were initiated. GSHEE was present during CM-
DCFH loading and during the contractions. To conserve GSHEE, the chamber was not 
perfused with solution during contractions. With the absence of perfusion, we observed 
greater baseline CM-DCF fluorescence compared with the baseline fluorescence when 
solution was flowing (Table 2.1), possibly due to lower rates of leakage of the indicator 
from the muscles. Control muscles were treated the same as muscles exposed to 
GSHEE, except that GSHEE was not present.  
Muscle cross-sectional area measurements. After testing, muscles were 
maintained at optimal length while the testing chamber was placed on the stage of a 
stereo microscope (MZ8, Leica Microsystems). The diameter of the muscle was 
measured using a scale in the eye piece of the microscope and the cross-sectional 
muscle area (CSA) was estimated by assuming a circular cross-section. 
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Data analysis. ROS oxidize CM-DCFH to form the fluorescent product CM-DCF, 
and the net increase in ROS over time is indicated by the increase in CM-DCF 
fluorescence over time (15, 20, 35). Therefore, we determined the “CM-DCF slope” (i.e. 
slope of the CM-DCF fluorescence-versus-time plot) during a resting period and during 
IC. In order to quantify the change in slope with the onset of contractions, we subtracted 
the slope of a line fitted to the baseline portion of the CM-DCF fluorescence record 
(dashed line, Figure 2.1) from the slope of a line fitted to the portion of the record 
corresponding to the series of contractions (dotted line, Figure 2.1). We considered only 
the CM-DCF fluorescence measurements collected after each contraction (i.e. after the 
force returned to the baseline value) to prevent motion artifact from affecting the 
analysis. Background fluorescence was subtracted from the CM-DCF fluorescence 
record before the slopes were calculated. The analysis was the same for muscles 
subjected to lengthening contractions and passive stretches.  
Statistics. Data are presented as mean ± SD. Differences between experimental 
groups were analyzed by a Student’s t test or a one-way ANOVA followed by the Holm-
Sidak method to determine which means were significantly different. In the case of 
skewed distributions or unequal variance, a Mann-Whitney rank sum test or a Kruskal-
Wallis one-way ANOVA on ranks was used. Correlation between two variables was 
determined by calculating the Pearson product-moment correlation coefficient. 
Differences were considered statistically significant when P < 0.05. 
 
 
 
 
 
25	  
Results 
 
To test our hypothesis that lengthening contractions that damage the muscle 
generate more ROS than isometric contractions, we subjected LMB muscles to LC or 
IC, with PS as an additional control, and examined changes in CM-DCF slope (Figures 
2.1-2.3). As expected, LC caused muscle damage as indicated by a ~30% force deficit, 
whereas IC and PS produced no or minimal force deficits, respectively (Figure 2.3A). 
The CM-DCF slope increased during IC and LC relative to baseline slopes; however, 
the increase observed with the onset of LC was not greater than the increase observed 
with the onset of IC (Figure 2.3B). We did not detect a change in CM-DCF slope with 
the onset of PS (Figure 2.3B) and so we excluded PS from subsequent experiments. 
Since we did not find that LC increased the CM-DCF slope more than IC, we 
completed a second series of experiments to verify the result was not due to insufficient 
or excessive stretch. We subjected LMB muscles to lengthening contraction protocols 
with the magnitude of stretch ranging from 30-50% Lf, including 0% Lf (i.e. IC) as a 
control, and examined changes in CM-DCF slope (Figure 2.4). As expected, the force 
deficit increased as the degree of stretch increased (Figure 2.4A). However, despite the 
large range of stretch and damage among groups, there were no differences in the 
change in CM-DCF slope with the onset of LC (Figure 2.4B). In case the effects of LC 
were not immediately apparent, we also examined the CM-DCF slope 10 min after LC, 
during an additional isometric contraction protocol. Prior to the isometric contraction 
protocol, the baseline DCF slope was not different between injured and uninjured 
muscles. In contrast, we found that the change in CM-DCF slope with the onset of 
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contractions was significantly less in muscles initially stretched by 50% Lf (Figure 2.4C), 
and within this group the force deficit and the change in CM-DCF slope were negatively 
correlated (Figure 2.4D). Overall, the second series of experiments confirmed our 
finding that LC did not increase CM-DCF slope more than IC.  
In order to confirm that CM-DCF slope was sensitive to ROS in LMB muscles, we 
conducted a third series of experiments. CM-DCF slope was examined after LMB 
muscles were exposed to GSHEE. GSHEE is converted to the antioxidant GSH once it 
crosses the cell membrane and decreases contraction-induced ROS generation in 
single muscle fibers (15). GSHEE decreased both the baseline CM-DCF slope (Figure 
2.5A) and the change in CM-DCF slope with the onset of IC, compared with controls 
(Figure 2.5B). GSHEE exposure did not reduce force (Figure 2.5C) indicating that 
GSHEE did not damage LMB muscles or impair muscle activation. These results 
suggest that the decrease in CM-DCF slope was due to an increase in GSH content, 
not impaired muscle function, and verified that CM-DCF slope is sensitive to net 
changes in ROS in whole LMB muscles.  
Finally, our findings were not due to intrinsic differences among experimental 
groups. Prior to IC, LC, or PS, there were no differences in muscle size (i.e. fiber length 
and CSA), pre-protocol force, or baseline CM-DCF slope among experimental groups, 
except for a difference in baseline CM-DCF between muscles exposed to GSHEE 
relative to controls (Table 2.1).  
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Discussion 
 
The main finding of the present study is that, contrary to our hypothesis, 
lengthening contractions that damage muscle do not generate more ROS than isometric 
contractions that do not cause damage. This finding is supported by the observation 
that lengthening contraction protocols with stretches of 30, 40, and 50% Lf clearly 
damaged mouse LMB muscles as shown by deficits in isometric force, but the increase 
in CM-DCF slope associated with each of the lengthening contraction protocols was not 
different from the increase associated with isometric contractions.  
Our main finding is consistent with other studies. Kon and colleagues quantified 
thiobarbituric acid reactive substances (TBARS) levels in mouse tibialis anterior (TA) 
muscles immediately after 12 min of lengthening contractions in situ. TBARS were 
elevated after the lengthening contractions, but the increase was not different from the 
increase observed after shortening contractions (36). Another in situ study analyzed 
2′,7′-dichlorofluorescein (DCF) fluorescence, melondialdehyde (MDA) levels, 
glutathione, and antioxidant enzyme activity in muscle homogenates immediately after 
single lengthening contractions of rabbit TA muscles. DCF fluorescence and MDA levels 
were not elevated in injured muscles compared with sham controls, and glutathione 
content and antioxidant enzyme activity did not appear to differ between injured 
muscles and controls (37). Neither of these studies examined ROS generation during 
the lengthening contractions, but measures of ROS were not elevated shortly after 
lengthening contractions beyond control levels and are therefore consistent with our 
main finding. Several studies report an elevation in ROS after injury, but these studies 
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do not conflict with ours since the elevation is observed hours to days after the initial 
injury and are primarily attributed to invading inflammatory cells (17, 36, 38, 39). 
Although our observation that ROS levels produced during damaging and non-
damaging contraction protocols were not different suggests that changes in the 
magnitude of ROS generation at the time of injury is not an initiating signal for 
subsequent inflammation, degeneration, necrosis, or regeneration, our data do not 
completely rule out a role for ROS in the initiation of degenerative or regenerative 
processes after injury. ROS indicators based on DCFH or DCFH derivatives are 
sensitive to a variety of ROS and oxidizing reactions (40). Therefore, the possibility 
remains that variations in the specific ROS generated by isometric and lengthening 
contractions may be different although the overall magnitude of detected ROS was not. 
Moreover, DCFH-based indicators are generally not sensitive to superoxide and show 
variable sensitivities to nitric oxide and peroxynitrite (40), allowing for the possibility that 
some ROS vary between isometric and lengthening contractions but were not detected 
by CM-DCFH in the present study. The fact that a variety of ROS measures failed to 
show differences after lengthening contractions versus controls argues against this 
possibility (36, 37). ROS are not only generated within muscle fibers (37, 44, 29, 51, 
18), but are also released from muscle during contractions (14, 42, 43). ROS released 
from muscle fibers may contribute to degenerative or regenerative processes following 
injury, based on the modulation of injury caused by manipulation of extracellular 
antioxidants (44, 45). Because CM-DCFH is retained within the muscle fibers, released 
ROS were not detected in the present study, and we are unable to rule out the 
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possibility that extracellular ROS are involved in the initiation of downstream processes 
after injury. 
An additional finding of our study was that muscles that were initially exposed to 
lengthening contractions with stretches of 50% Lf showed reduced ROS generation 
during a subsequent series of isometric contractions, compared with controls. Moreover, 
within this experimental group, there was a negative correlation between the force 
deficit induced by the stretches of 50% Lf and the change in CM-DCF slope during the 
isometric contractions performed after 10 min. This observation indicates that greater 
damage correlated with less ROS generation during ensuing contractions. Although this 
relationship does not necessarily imply causation, if enough damage occurs during 
lengthening contractions (e.g. 60% force deficit as in the LC group with stretches of 
50% Lf), the muscle’s ability to produce ROS appears to be impaired. Force dropped 
steadily during the LC protocol with stretches of 50% Lf, likely due to mechanical 
damage to force generating or force transmitting structures (46, 47) or the excitation-
contraction coupling apparatus (48), but this damage did not appear to immediately 
disrupt the pathways involved in ROS production, as the “ROS deficit” was not apparent 
until 10 min later. To our knowledge a link between muscle damage and an impaired 
ability to produce ROS has not been established and we cannot speculate regarding the 
mechanism at this time. The link between muscle damage and ROS generation may 
represent an interesting topic of exploration in future studies, although in vivo strains of 
approximately 50% relative to fiber (fascicle) length seem to indicate an upper limit (29-
33) and the result described here may only be applicable in rare instances of severe 
stretch.  
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Our hypothesis was partially based on the expectation that passive stretches 
would generate ROS, but we did not detect an increase in CM-DCF fluorescence during 
passive stretches. In agreement with our findings, passive stretches of single flexor 
digitorum brevis (FDB) fibers estimated to be of 10-15% strain did not increase 6-
carboxy-2′,7′-dichlorofluorescein fluorescence (25) or CM-DCF fluorescence (23), 
although contradictory findings have been reported. DCF fluorescence increased during 
stretches of 20% of whole extensor digitorum longus muscles (22), 15% of strain of 
C2C12 myotubes (22), and 8% stretch of cardiac myocytes (24), and ethidium 
fluorescence was increased after 15% stretches of single FDB fibers (23). Conflicting 
results may be due to variations in stretch protocols, indicators, and cell or muscle type, 
or ROS generation during passive stretch may sometimes fall below the detection limits 
of commonly used methods. In any case, our results suggest that any production of 
ROS elicited by passively stretching muscles is minimal in comparison to the ROS 
produced as a byproduct of contractile activity. 
Our main finding that lengthening contractions do not generate more intracellular 
ROS than isometric contractions has several implications. First, the magnitude of 
intracellular ROS generated at the time of injury is probably not an initiating signal for 
subsequent inflammation, degeneration, necrosis, and regeneration, although other 
aspects of ROS generation (e.g. composition or localization) may be important. A 
second implication of our finding is that the sources responsible for contraction-induced 
ROS generation are not sensitive to stretch. Although we did not examine the source of 
ROS generation in the present study, others have suggested that non-mitochondrial 
sources (18, 19) and specifically, NADPH oxidase (20, 21) contribute to ROS 
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generation during muscle contractions. While NADPH oxidase appears to be stretch-
sensitive in cardiac muscle cells (24), this may not be the case in skeletal muscle. 
Finally, our data suggest that ROS generation during muscle contraction is highly 
robust. The ability to produce ROS was intact during and immediately after damaging 
lengthening contractions, except under circumstances of large stretch and severe 
damage. One could speculate that beneficial adaptations thought to result from ROS 
production during contractions (49, 50) can occur despite moderate muscle damage.	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Figure 2.1: Representative force responses during a single isometric contraction, 
lengthening contraction and passive stretch. Imposed length change and activation 
stimuli are also shown.  
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Figure 2.2:  Representative force responses during series of 12 isometric contractions, 
lengthening contractions, and passive stretches, and simultaneous CM-DCF records. 
Lines were fit to the CM-DCF fluorescence signal during a resting period (dashed line) 
and during the contractions (dotted line) and the slopes were calculated. The same 
analysis was performed for lengthening contraction and passive stretch protocols. 
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Figure 2.3: Effect of isometric contractions, lengthening contractions (40% Lf), and 
passive stretches (40% Lf) on (A) force deficit and (B) change in CM-DCF slope. Force 
deficits are expressed as a percentage of the pre-protocol force and each symbol 
represents data from an individual muscle. Horizontal lines indicate the mean force 
deficit for each group. Changes in the slope of the CM-DCF fluorescence are expressed 
in photon counts per second per second and each bar represents the means ± SD. 
∗indicates significant difference from the other two groups. The number of LMB muscles 
= 14 (IC), 6 (LC), and 6 (PS). 
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Figure 2.4: Effect of lengthening contractions on (A) force deficit and (B) change in CM-
DCF slope for stretches of several magnitudes expressed as a percentage of muscle 
fiber length (% Lf). Force deficits are expressed as a percentage of the pre-protocol 
force and each symbol represents data from an individual muscle. Horizontal lines 
indicate the mean force deficit for each group. LC with 30% and 50% stretches 
produced force deficits while LC with 10% and 0% stretches did not. ∗indicates 
significant difference from 0% and 10% groups and #indicates significant difference 
from 30% group. Changes in the slope of the CM-DCF fluorescence are expressed in 
photon counts per second per second and each bar indicates the mean ± SD. There 
were no differences between groups. (C) Changes in CM-DCF slope during IC 
performed ten minutes after LC with stretches of several magnitudes. Each bar 
indicates the mean ± SD. ∗indicates significant difference from 0% group. (D) Negative 
correlation between the change in CM-DCF slope 10 min after LC (stretches of 50% Lf) 
and the force deficit. Each symbol represents data from an individual muscle. The 
number of LMB muscles = 8 (0%), 6 (10%), 6 (30%), and 7 (50%). 
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Figure 2.5: Data are shown for (A) baseline CM-DCF slope, (B) the change in CM-DCF 
slope with the onset of isometric contractions, and (C) force generation in millinewtons 
for control LMB muscles (black bars) and LMB muscles exposed to glutathione reduced 
ethyl ester (GSHEE) treatment (gray bars). ∗indicates significant difference from control 
group. The number of LMB muscles = 3 (Control) and 3 (GSHEE). 
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Experiment 
series and 
group 
Number 
of LMB 
muscles* 
Fiber length 
(mm) CSA (mm²) 
Pre-
protocol 
force (mN) 
Baseline CM-
DCF slope 
(photon 
counts/s/s) 
Series 1:      
   IC      14 2.1 ± 0.4† 0.13 ± 0.02 19.7 ± 2.3   23 ± 21 
   LC     6 1.9 ± 0.2   0.13 ± 0.01 19.1 ± 1.4   16 ± 19 
   PS     6 2.1 ± 0.2 0.13 ± 0.02 19.2 ± 1.2     9 ± 13 
      
Series 2:      
   0%      8 2.0 ± 0.3 0.12 ± 0.01 18.9 ± 2.4    -3 ± 25 
   10%     6 2.2 ± 0.3 0.12 ± 0.01 18.5 ± 2.5   13 ± 13 
   30%      6 1.8 ± 0.2 0.12 ± 0.02 18.8 ± 2.4   11 ± 13 
   50%     7 1.8 ± 0.2 0.13 ± 0.01 19.1 ± 3.4   10 ± 28 
      
Series 3:      
   Control      3 2.1 ± 0.3 0.13 ± 0.01 17.5 ± 1.7 140 ± 20 
   GSHEE     3 2.0 ± 0.3 0.13 ± 0.02 18.6 ± 2.1   10 ± 09‡ 
 
Table 2.1: Experimental groups of LMB muscles are not different prior to IC, LC, or PS. 
Comparisons are made between experimental groups within each series of 
experiments. Values are means ± SD.*1 LMB muscle taken from each mouse.†1 value 
missing. ‡significantly different from control group 
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Chapter 3 
 
Impaired regeneration in old mice is associated with elevated neutrophil and 
macrophage accumulation and altered expression of macrophage-related genes  
 
Abstract 
 
Aging is associated with delayed and possibly incomplete repair after skeletal 
muscle injury, but the underlying mechanisms are not entirely understood. We 
hypothesized that age-related deficiency in muscle repair is associated with an 
inappropriate myeloid cell response, specifically a persistence of neutrophils and a 
delay or reduction in the accumulation of macrophages, especially anti-inflammatory 
(M2) macrophages. To test our hypothesis, we injured muscles of young and old mice 
with lengthening contractions in situ and analyzed the muscles 2 or 5 d later. 
Regardless of age, injury increased neutrophil (Gr-1+), total macrophage (CD68+) and 
M2 macrophage (CD163+) content by 2 d. By 5 d, neutrophils declined and total 
macrophages increased dramatically while M2 macrophages increased to a lesser 
extent. We found no evidence of persisting neutrophils or reduced accumulation of M2 
macrophages in old muscles. Instead, we generally found more neutrophils and 
macrophages (total and M2) in muscles of old mice at both time points. Messenger RNA 
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levels suggested age-related changes in the expression of macrophage-associated 
genes that have the potential to undermine or impair muscle regeneration. Therefore, 
the mechanism underlying age-related deficiency in muscle repair may involve altered 
macrophage function in old mice. 
 
Introduction 
 
Skeletal muscle injuries are common and have a variety of causes, including 
physical trauma, extreme temperatures, toxin exposure, invasive surgery, 
ischemia/reperfusion and unloading/reloading. Muscles can also be injured by their own 
contractions, especially during lengthening contractions when muscles are stretched 
while activated. Regardless of the cause, the initial insult is followed by degeneration 
and necrosis of damaged muscle fibers and subsequent regeneration and repair. 
Muscle repair is delayed and possibly incomplete with advanced age. After injury, 
muscles from old animals have fewer and smaller regenerating fibers (1, 2), more 
fibrosis (3-6) and more fat (6) compared with young controls. Failed restoration of 
normal muscle structure is accompanied by persistent and likely permanent deficits in 
force generation (7-10). Although the age-related deficiency in muscle repair is well 
established, the underlying mechanisms are incompletely understood.  
Successful muscle regeneration relies on muscle stem cells known as satellite 
cells. In response to injury, satellite cells exit their normal quiescent state and 
proliferate, differentiate, and fuse together to form new myofibers or fuse to existing 
fibers to repair damage (11). Satellite cells from old animals are capable of repair, but 
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systemic and local aspects of the aged environment hinder the ability of satellite cells to 
successfully regenerate injured muscle (2, 12-14). Myeloid cells accumulate in injured 
muscle and thus contribute to the local environment of satellite cells, and a growing 
body of evidence suggests that myeloid cells play critical roles in muscle repair and 
regeneration. Neutrophils are the first to accumulate in injured muscle, arriving from the 
circulation within hours of the initial insult. The contribution of neutrophils to muscle 
repair is not well understood. Possible beneficial roles include facilitating the removal of 
damaged or necrotic tissue and contributing to subsequent macrophage accumulation 
(15). However, neutrophils may undermine the repair process by exacerbating damage 
to muscle fibers. Neutrophils can lyse muscle cells in vitro and damage membranes in 
vivo by mechanisms involving reactive oxygen species (16, 17), and preventing 
neutrophil infiltration after injury has been reported to reduce force deficits and 
histological damage to muscle fibers (18-21). 
Following the arrival of neutrophils, macrophages begin to accumulate in injured 
muscle. Macrophage accumulation is thought to arise from the infiltration and 
differentiation of circulating monocytes, but the proliferation of macrophages that are 
already present in the muscle may also contribute (22, 23). Macrophages generally 
contribute to muscle repair. Preventing or delaying the accumulation of monocytes 
and/or macrophages induced by muscle injury results in delayed clearance of necrotic 
fibers, fewer or smaller regenerating fibers, increased fibrosis and more fat relative to 
controls (22, 24-28). 
The mechanisms by which macrophages contribute to muscle repair appear to 
depend on macrophage phenotype. In vitro, macrophages can take on pro-inflammatory 
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(M1) or anti-inflammatory (M2) phenotypes based on their environment. After muscle 
injury in vivo, pro- and anti-inflammatory macrophages are also observed and have 
been referred to as M1 and M2 macrophages, although in the complex in vivo 
environment, macrophages do not perfectly conform to phenotypic categories defined in 
vitro (29, 30). After injury, M1 macrophages accumulate within 1-2 days. Because they 
invade muscle fibers, they are thought to contribute to repair by the removal of 
damaged or necrotic tissue (31-33). M1 macrophage numbers decline within a few days 
as the number of M2 macrophages increases. M2 macrophages can remain in the 
muscle for many days and their presence generally coincides with the regenerative 
stage of muscle repair (31-33). M2 macrophages may contribute to muscle repair by 
regulating satellite cell function, as M2 macrophages have been reported to stimulate 
proliferation and differentiation of muscle precursor cells in vitro (22, 33, 34). 
The shift from M1 to M2 macrophages appears to be important for successful 
muscle regeneration. The M1 to M2 phenotype shift was impaired in mice deficient in IL-
10 after muscle injury and was associated with persistent muscle membrane lesions, 
fewer regenerating fibers and reduced fiber growth in comparison to wild type mice (33). 
An impaired or delayed shift from M1 to M2 macrophages could be detrimental due to 
the persistence of M1 macrophages or due to the decreased number of M2 
macrophages, as mice carrying a mutation that blocked downstream induction of M2- 
but not M1-specific genes showed severe defects in muscle fiber regeneration (35). 
Despite the impairments in muscle regeneration observed in old animals as well 
as the accumulating evidence that myeloid cells play a critical role in muscle repair 
following injury, the effect of aging on the magnitude and timing of the myeloid cell 
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response has received little attention. The degree to which the myeloid cell response 
changes with age or how the changes may be associated with the age-related 
deficiency in muscle repair is largely unknown. Therefore, in the present study we 
tested the hypothesis that age-related deficiency in muscle repair is associated with an 
inappropriate myeloid cell response, specifically a persistence of neutrophils and either 
impaired total macrophage accumulation or a delayed switch from M1 to M2 
macrophages. To test our hypothesis, we injured muscles of young and old mice with 
lengthening contractions in situ and analyzed the muscles 2 or 5 days later. Muscle 
damage and repair was determined by functional and histological measures, neutrophil 
and macrophage content was determined by immunohistochemistry and 
immunofluorescence, and myeloid cell function was studied by RT-qPCR.  
 
Methods  
 
Animals. Male C57BL6 young (3-5 mo) and old (25-27 mo) mice were housed in 
a specific-pathogen-free facility at the University of Michigan until experimentation. 
Between experimental procedures, mice were housed in a separate specific-pathogen-
free return room. All animal use procedures were approved by the University of 
Michigan Committee on the Use and Care of Animals (UCUCA). 
In situ evaluation of contractile properties. Procedures for in situ evaluation of 
muscle contractile properties were based on previous studies (7, 36). Each mouse was 
anesthetized with 3% isoflurane in oxygen delivered at a rate of 1 L/min. Anesthesia 
was maintained throughout in situ procedures with 2% isoflurane in oxygen and depth of 
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anesthesia was confirmed by failure of the mouse to respond to tactile stimuli. 
Ophthalmic ointment was placed on the mouse’s eyes to prevent corneal drying and 
trauma and this was re-administered throughout in situ procedures. The mouse was 
placed on a platform warmed to 37 °C with a circulating water bath. The hind limb fur 
was removed with animal clippers followed by a minimal amount of fur removal cream. 
The skin was disinfected with chlorhexidine and a small incision was made at the ankle 
to expose the distal tendon of the EDL muscle. Another small incision was made distal 
to the knee to expose the peroneal nerve. A secure knot was tied around the tendon 
with 6.0 braided silk suture. The hind limb was immobilized by pinching the knee and 
the foot with small clamps secured to the platform. Using the tails of the silk suture, the 
intact tendon was tied to the lever arm of a servomotor (300C-LR-FP, Aurora Scientific), 
which controlled the length of the muscle and measured the force generated. A 
computer with custom-designed software controlled stimulus pulses, the servomotor, 
and collected and stored force data. The small area of exposed tendon was kept moist 
by frequent administration of sterile saline. The EDL muscle was activated using a 
stimulator (701C, Aurora Scientific) and platinum electrodes placed under the peroneal 
nerve. A stimulus pulse duration of 0.2 ms was used for all contractions. Stimulation 
current and muscle length were adjusted in order to elicit maximum twitch force. Tetanic 
contractions of 200 ms duration were elicited with trains of pulses and the frequency of 
the pulses was increased until the force plateaued at the maximum isometric force (Po), 
typically at a frequency of 200 Hz. Finally, small adjustments in the ankle position were 
made to elicit maximum isometric tetanic force. The tetanic contractions were spaced 1 
min apart to prevent fatigue. Optimal muscle length (Lo), defined as the muscle length at 
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which maximum isometric force is achieved, was measured with calipers using the knee 
to estimate the location of the proximal end of the EDL muscle. Optimal muscle fiber 
length (Lf) was determined by multiplying Lo by the previously determined Lf-to-Lo ratio 
of 0.45 (37). 
In situ lengthening contraction protocol. Following evaluation of contractile 
properties, the EDL muscle was exposed to a protocol of 75 lengthening contractions 
spaced 4 s apart for a total duration of 5 min. Each contraction was 300 ms in duration. 
100 ms after the onset of stimulation, near maximum isometric force was generated and 
a stretch of 20% strain relative to Lf was initiated. Muscles were lengthened at the 
appropriate rate (1 Lf/s) to cause the peak of the stretch to coincide with the end of the 
tetanic stimulation. Ten minutes after the lengthening contraction protocol, the muscle 
was re-lengthened to achieve maximum twitch tension and Po was re-measured. The 
small incisions at the ankle and distal to the knee were closed with 7.0 sterile 
monofilament nylon suture and bathed with povidone-iodine solution, and mice were 
monitored until they recovered from anesthesia. 
In vitro evaluation of contractile properties. Two or five days following 
administration of the lengthening contraction protocol, mice were again evaluated for Po. 
Procedures for the in vitro evaluation of EDL contractile properties have been previously 
published (37). Each mouse was anesthetized with an intraperitoneal injection of Avertin 
(tribromoethanol, 250 mg/kg) (chemical components from Sigma-Aldrich). After the 
mouse was unresponsive to a tactile stimulus, the injured EDL muscle was isolated 
from the hindlimb of the mouse. 5-0 silk suture was tied to the proximal and distal 
tendons of the muscle and the muscle was placed into a chamber containing Krebs 
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Mammalian Ringer solution composed of (in mM): 137 NaCl, 5 KCl, 2 CaCl2·2H2O, 1 
MgSO4·7H2O, 1 NaH2PO4, 24 NaHCO3, 11 glucose, 0.03 tubocurarine chloride. The 
solution was maintained at 25 °C and bubbled with 95% O2-5% CO2 to maintain a pH of 
7.4. The proximal tendon was attached to a stationary object and the distal tendon was 
attached to a force transducer (BG-50, Kulite Semiconductor Products). Muscle 
activation was accomplished by electric field stimulation via a high-power current 
stimulator (701C, Aurora Scientific) and parallel plate electrodes.  
A computer and custom-designed software controlled stimulus pulses and 
collected and stored force data. Stimulus pulses of 0.2 ms in duration were used for all 
contractions. Stimulation current and the muscle length were adjusted in order to elicit 
maximum twitch force. A digital calipers was used to measure Lo. Muscles were held at 
Lo and tetanic contractions of 300 ms in duration were elicited with trains of pulses. The 
frequency of the pulses was increased until the force plateaued at Po, typically at 
frequencies from 150-200 Hz. The tetanic contractions were spaced 1 min apart to 
prevent fatigue. Optimal muscle fiber length (Lf) was determined as previously 
mentioned. Force deficit was defined as the difference between the Po measured 
immediately prior to lengthening contractions and the Po measured two days after 
lengthening contractions expressed as a percentage of the pre-injury Po. Following 
evaluation of the injured EDL, the contralateral EDL was removed and evaluated as 
described. Muscles were trimmed of their tendons, weighed, and cut in half. Half of 
each muscle was immersed in Tissue Freezing Medium (Electron Microscopy Sciences) 
and frozen in isopentane cooled by liquid nitrogen. The other half of each muscle was 
submerged in an RNA stabilization reagent (RNAlater, QIAGEN). The mouse was 
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euthanized with an overdose of Avertin followed by induction of a bilateral 
pneumothorax. 
Histology, immunohistochemistry and immunofluorescence. EDL muscles were 
cut into 10 µm thick sections on a cryostat. The sections were fixed in cold acetone and 
stained with Hematoxylin (Ricca Chemical Company) and Eosin Y (EMD Millipore). The 
number of injured fibers was counted per section and expressed as a percentage of the 
total number of fibers. Injured fibers included those with a swollen appearance, pale or 
variable staining, and obvious infiltration of inflammatory cells (36). Basophilic fibers 
with central nuclei were identified as regenerating fibers (38). An image analysis 
program (Image J) was used to count fibers and measure cross-sectional areas of 
entire sections and individual regenerating fibers. 
Muscle sections were analyzed for neutrophil and macrophage content using 
immunohistochemistry. Sections were fixed in cold acetone and air-dried. Sections were 
exposed to BLOXALL solution to block endogenous peroxidase activity followed by 10% 
normal rabbit or goat serum in PBS (Phosphate Buffer Solution, Fisher Scientific) to 
block non-specific binding of subsequent antibodies. Neutrophils were detected with a 
rat anti-mouse Gr-1 antibody (RB6-8C5, 1:50 dilution, BD Pharmingen, 550291) diluted 
in PBS containing 10% rabbit serum and macrophages were detected with a rat anti-
mouse CD68 antibody (FA-11, 1:1000, AbD Serotec, MCA1957) diluted in PBS 
containing 10% rabbit serum or with a rabbit anti-mouse CD163 antibody (M-96, 1:1000, 
Santa Cruz Biotechnology, sc-33560) diluted in PBS containing 10% goat serum. After 
incubation in primary antibodies, sections were exposed to biotinylated mouse adsorbed 
rabbit anti-rat IgG (Gr-1 and CD68) or biotinylated goat anti-rabbit IgG (CD163) in PBS 
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containing 10% rabbit or goat serum, respectively. Following exposure to the secondary 
antibodies, the sections were treated with the VECTASTAIN Elite ABC reagent 
containing peroxidase followed by the peroxidase substrate 3, 3’-diaminobenzidine 
(ImmPACT DAB). The sections were rinsed with PBS after each step except after the 
treatment with serum. All reagents were from Vector Laboratories unless stated 
otherwise. The Image J program was used to count the number of neutrophils or 
macrophages in one transverse section from the middle of each muscle. In the 
periphery, neutrophils express high levels of Gr-1 while monocytes express low or no 
levels of Gr-1 (39). Therefore, dark brown cells indicating high levels of Gr-1 were 
counted as neutrophils while the occasional light brown cell of similar size was not 
counted. Both light and dark brown cells were counted as macrophages in sections 
treated with reagents for CD68 and CD163 detection. The Image J program was used 
to calculate the area of each section and neutrophil or macrophage content was 
expressed per mm3 of muscle. We also normalized neutrophil and macrophage content 
to the initial force deficit in order to provide a measure of the cellular response to a 
given amount of damage. Initial force deficit provides a valid and reproducible measure 
of the totality of the injury (40) and therefore we used the initial force deficit as a 
measure of initial damage. 
 Some muscle sections were analyzed for double labeling of either CD68 and 
CD163 or CD163 and CD301 with immunofluorescence. Sections were fixed in cold 
acetone and air-dried. Sections were exposed to 1% BSA (Jackson ImmunoResearch 
Laboratories) in PBS to block non-specific binding of subsequent antibodies and then 
exposed to a mixture of primary antibodies in PBS containing 1% BSA. To detect CD68 
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and CD163, the primary antibodies and concentrations were the same as for 
immunohistochemistry, except that anti-CD163 was diluted to 1:200 for 
immunofluorescence. To detect CD301, a goat anti-mouse CD301 IgG antibody was 
used (1:400, R&D Systems, AF4938). After exposure to primary antibodies, the sections 
were exposed to a mixture of appropriate secondary antibodies in PBS containing 1% 
BSA. Secondary antibodies were Alexa Fluor 594 goat anti-rat IgG (112-585-167), 
Alexa Fluor 594 bovine anti-goat IgG (805-585-180), and Alexa Fluor 488 donkey anti-
rabbit IgG (711-545-152) and were purchased from Jackson ImmunoResearch 
Laboratories. Sections were then exposed to DAPI (D9564, Sigma-Aldrich) to detect 
nuclei and treated with ProLong Gold Antifade Reagent (P36930, Life Technologies). 
The sections were rinsed with PBS after each step except after the treatment with 1% 
BSA. All sections for histology, immunohistochemistry, and immunofluorescence were 
imaged with a Nikon E-800 microscope. 
Blood analysis. Blood was collected via a scalpel nick of the lateral tail vein (50-
100 µl). Whole blood was analyzed with a cell counter (Hemavet 950FS, Drew 
Scientific) to determine circulating white blood cell counts. 
Gene expression. Muscle halves were homogenized in QIAzol lysis reagent 
(QIAGEN). RNA was isolated using an miRNeasy Mini Kit (QIAGEN) and treated with 
DNase I (QIAGEN). RNA concentration was measured with a NanoDrop 2000 
Spectrophotometer (Thermo Scientific). RNA (2  µg) was reverse transcribed using a 
QuantiTect Reverse Transcription Kit (QIAGEN), and cDNA was diluted by 5-fold and 
amplified in a CFX96 real time thermal cycler (Bio-Rad) using a QuantiTect SYBR 
Green I PCR Kit (QIAGEN) and primers specific for inducible nitric oxide synthase 
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(iNOS) (41), tumor necrosis factor alpha (TNFα) (41), arginase-1 (Arg1) (33), 
interleukin-10 (IL-10) (33), and β2-microglobulin (42). Primers were purchased from 
Integrated DNA Technologies and primer concentration was adjusted to yield PCR 
efficiencies between 90 and 110%. The presence of single amplicons from qPCR 
reactions was verified using melting curve analysis. Reactions were performed in 
duplicate. Preliminary work revealed that mRNA from target genes was undetectable in 
contralateral muscles so we completed our analysis using only injured muscles. 
Messenger RNA levels of β2-microglobulin were not altered by age but were elevated 5 
days after lengthening contractions relative to 2 days after lengthening contractions. 
Therefore, we normalized mRNA transcripts to β2-microglobulin and compared young 
and old samples within each time point. Messenger RNA levels were analyzed by the 
comparative CT method (43).  
Data analysis. Data are expressed as means ± 1 SEM. To compare two groups, 
Student’s t-tests were used and in cases of non-normal distributions or unequal 
variance, a Mann-Whitney Rank Sum test was used. To compare multiple groups, a 
Two Way ANOVA (Age x Day) was used and in cases of non-normal distributions or 
unequal variance, the data was ranked and a Two Way ANOVA (Age x Day) was used. 
Significance was set a priori at P < 0.05.  
 
Results   
 
General characteristics of young (3-5 mo) and old (25-27 mo) groups are shown 
in Table 1. Muscles from old mice were weaker by all measures (Table 3.1). We did not 
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detect a significant difference in muscle mass between young and old mice but cross-
sectional areas indicated that muscles from old mice were smaller than young (Table 
3.1).  
Unexpectedly, lengthening contractions caused slightly less initial damage in 
muscles from old mice relative to young, as assessed by the initial force deficit 
measured 10 minutes following the lengthening contraction protocol (Figure 3.1). The 
level of damage increased between 2 and 5 days after lengthening contractions for both 
age groups as indicated by increases in both force deficit and in the number of muscle 
fibers showing signs of histological damage as well as a decrease in the total number of 
fibers (Figure 3.2). Consistent with less initial damage in muscles from old mice, there 
was less damage in muscles from old mice 2 and 5 days after lengthening contractions, 
relative to young, according to several measures. Force deficit and the percentage of 
muscle fibers showing signs of histological damage were lower for muscles of old 
compared with young mice (Figures 3.2A-3.2B). Finally, the total number of fibers 
remaining in a cross-section 5 days after lengthening contractions was larger in the 
muscles of old compared with young mice, suggesting that fewer muscle fibers had 
completely degenerated in old mice by this time point (Figure 3.2C). 
Regenerating fibers were detected in sections from muscles taken 5 days after 
lengthening contractions. Injured muscles from old mice contained fewer regenerating 
fibers relative to young, but the difference was not significant (Figure 3.3A). Since fewer 
regenerating fibers in muscle sections of old mice could be due to less initial damage in 
this group, we also assessed the cross-sectional area of regenerating fibers as a 
measure of regeneration. In spite of less initial damage in muscles from old mice, 
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regenerating fibers in muscle sections from old mice were smaller relative to young 
(Figures 3.3B-3.3D), consistent with delayed or deficient repair with age.   
 Neutrophil (Gr-1+ cell) content in muscles from young and old mice increased 
relative to control levels by 2 days after lengthening contractions (Table 3.2, Figure 3.4, 
P < 0.001 by Two Way (age x injury) ANOVA, injury effect) and then declined between 2 
and 5 days after lengthening contractions (Figure 3.4). Neutrophil content was greater in 
old mice relative to young in control muscles (Table 3.2) and after lengthening 
contractions (Figure 3.4). The age-associated differences in neutrophil content between 
young and old mice were amplified when neutrophil content was normalized to initial 
damage (Figure 3.4B).    
The selection of macrophage markers was guided by immunofluorescence data 
(Figures 3.5-3.6). Mouse CD68 (rat ED1+) is expressed on macrophages and labels 
early-invading macrophages that accumulate in injured skeletal muscle and invade 
muscle fibers (32, 33, 44, 45). We originally planned to use CD68 as a marker of M1 
macrophages, but immunofluorescence showed that cells that were CD163+ were also 
CD68+ (Figure 3.5). Therefore we used CD68 as a marker for total macrophage 
content. CD163 has been used as a marker of M2 macrophages. Mouse CD163 (rat 
ED2+) labels a population of macrophages that accumulate in injured muscle after 
CD68+ cells, do not invade muscle fibers and are associated with repair (31-33). 
Immunofluorescence showed that CD163 co-localized with CD301 (Figure 3.6). CD301 
is another marker of M2 macrophages (46, 47) and the co-localization supports the 
identification of CD163+ cells as M2 macrophages. 
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Total macrophage (CD68+ cell) content in muscles from young and old mice 
increased relative to control levels by 2 days after lengthening contractions (Table 3.2, 
Figure 3.7, P < 0.001 by Two Way (age x injury) ANOVA, injury effect) and increased 
further between 2 and 5 days after lengthening contractions (Figure 3.7). Total 
macrophage content was not different in control muscles of young and old mice (Table 
3.2) and was not different 2 days after lengthening contractions (Figure 3.7A). Five days 
after lengthening contractions total macrophage content was about 25% lower in muscle 
from old mice relative to young (Figure 3.7A). However, when total macrophage content 
was normalized to the amount of initial damage, the outcome was reversed. That is, for 
a given level of injury, the degree of macrophage accumulation was significantly greater 
in old mice relative to young at both 2 and 5 days after injury (Figure 3.7B).   
M2 macrophage (CD163+ cell) content in muscles from young and old mice 
increased relative to control levels by 2 days after lengthening contractions (Table 3.2, 
Figure 3.8, P = 0.036 by Two Way (age x injury) ANOVA, injury effect) and increased 
between 2 and 5 days after lengthening contractions (Figure 3.8). M2 macrophage 
content was greater in muscles of old compared with young mice both before (Table 
3.2) and after lengthening contractions (Figure 3.8). The higher levels of M2 
macrophages in muscles of old mice were observed despite less damage in old mice. 
Thus, the differences in M2 macrophage content between young and old mice were 
enhanced when M2 macrophage content was normalized to initial damage (Figure 
3.8B). 
Finally, we examined function of myeloid cells in injured muscles from young and 
old mice with a focus on macrophages, the dominant cell type. We examined 
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messenger RNA levels of genes expressed by M1 (iNOS, TNFα) or M2 (Arg1, IL-10) 
macrophages in injured muscles from young and old mice (Figure 3.9). In old injured 
muscles, mRNA levels of iNOS and TNFα were not different from young muscles 2 
days after lengthening contractions, but were significantly elevated over young levels 5 
days after lengthening contractions (Figures 3.9A-3.9D). Messenger RNA levels of Arg1 
were also not different between young and old muscles 2 days after lengthening 
contractions (Figure 3.9E). After 5 days, mRNA levels of Arg1 were increased in old 
muscles relative to young, but values from old animals were highly variable and the 
difference was not significant (Figure 3.9F, P = 0.083).  Two days after lengthening 
contractions, IL-10 mRNA levels were decreased in old muscles relative to young 
(Figure 3.9G) with no differences between groups 5 days after lengthening contractions 
(Figure 3.9H). 
Finally, we questioned whether enhanced neutrophil and macrophage content in 
injured muscles from old mice relative to young reflected a general increase in 
circulating levels of neutrophils and monocytes with age. In mice that were not 
subjected to lengthening contractions, circulating levels of neutrophils and monocytes 
were significantly greater in old animals relative to young (Figure 3.10). 
 
Discussion 
 
Our results indicate that the myeloid cell response to injury was altered in old 
mice relative to young. However, contrary to our hypothesis, the altered myeloid cell 
response was not characterized by a persistence of neutrophils, impaired total 
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macrophage accumulation, or a delay in the accumulation of M2 macrophages. The 
supporting evidence is that in old muscles, neutrophils did not remain elevated 5 days 
after lengthening contractions, but similar to the young group, declined between 2 and 5 
days. Neutrophil levels were greater 5 days after lengthening contractions in old 
muscles relative to young, but this does not reflect a persistence of neutrophils since 
quiescent muscles from old mice also had greater neutrophil content. Five days after 
injury, total macrophage content was about 25% less in muscles from old mice relative 
to young, but the smaller number may be explained by the proportional reduction 
(~20%) in initial damage in muscles of old mice relative to young rather than impaired 
macrophage accumulation. Furthermore, when total macrophage accumulation was 
normalized to the amount of initial damage, total numbers of macrophages in injured 
muscles from old mice were greater compared to the numbers observed in young mice. 
M2 macrophage content increased in injured muscles between 2 and 5 days after 
lengthening contractions for both young and old mice, but was greater in old muscles 
relative to young. Thus, neither total macrophage accumulation nor M2 macrophage 
accumulation was impaired in injured muscles from old mice. 
Although an age-related persistence or impaired/delayed accumulation of 
leukocytes after muscle injury has been suggested by other studies, these studies are 
limited by the use of nonspecific leukocyte markers, failure to quantify cellular or protein 
content, or a failure to normalize data to the amount of initial damage. Prolonged 
expression (mRNA) of inflammatory markers, including the leukocyte marker CD18, was 
observed in muscles from old rats up to 3 days after myotoxin injury (48). While this 
finding could reflect an age-related persistence of neutrophils, macrophage levels would 
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also affect CD18 expression and actual neutrophil and/or macrophage cell content was 
not examined. Hamada et al. 2005 found that CD18 mRNA levels were increased in 
vastus lateralis muscles of young subjects 3 days after downhill running but increased 
to a lesser degree in muscles of old subjects (49). This finding suggests impaired or 
delayed leukocyte infiltration with age, but a trend toward less damage in old subjects 
as reflected by serum levels of creatine kinase was also reported (49). Thus, reduced 
leukocyte recruitment could explain decreased CD18 mRNA levels, but cellular content 
of leukocytes was once again not assessed in injured muscles in the Hamada study. 
Sadeh reported delayed recruitment of macrophages in muscles from old rats injured 
with myotoxin relative to young controls (1). However, this qualitative study estimated 
macrophage numbers based on nuclei observed in muscle sections stained with H&E, 
which would represent multiple cell types including neutrophils and satellite cells. In 
contrast, the present study, which uses cell specific markers, can not only quantify 
neutrophil and macrophage content in injured muscles but can also interpret the data 
with a consideration of the amount of initial damage in young and old muscles.   
Instead of an age-related persistence of neutrophils or impaired or delayed 
macrophage accumulation after injury, the results indicated an enhanced response in 
the magnitude of neutrophils, total macrophages and M2 macrophages to injury in old 
relative to young mice. Our observations of enhanced neutrophil and macrophage 
accumulation in old mice in response to muscle injury is generally supported by other 
studies. Increased leukocyte infiltration was reported in muscles of old rats compared 
with young after ischemia/reperfusion injury of plantaris muscles (50). In addition, 
muscles from adult and old rats displayed elevated CD68 protein content relative to 
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young, 3 days after a contusion injury (5). Although CD68 content does not necessarily 
reflect the number of CD68+ cells, this finding generally agrees with ours. Koh et al. 
2003 assessed neutrophil (Ly6G+ cells) and macrophage (F4/80+ cells) content after 
lengthening contractions (51). The authors observed similar levels of injury in young and 
old groups as assessed by force deficit and the number of injured fibers, but observed 
almost a 2-fold increase in neutrophils and a trend toward increased macrophages in 
muscles from old animals relative to young, in agreement with our findings. However, an 
age-related increase in myeloid cell content after injury is not a universal finding. Paliwal 
et al. 2012 found no difference in leukocyte (CD11b+ cell) content in muscles from 
young and old mice 3 and 5 days after a cardiotoxin injury, as assessed by flow 
cytometry (52). Nevertheless, the majority of studies, including the present study, 
suggest an age-related increase in leukocyte content after muscle injury. 
Our observation of elevated levels of neutrophil and macrophage content in 
injured muscles from old mice relative to young may reflect a compensatory effect of 
impaired function of aged myeloid cells. In order to address this question, we measured 
mRNA levels of genes expressed by different myeloid cell populations after muscle 
injury. Consistent with previous reports of elevations in iNOS, TNFα, arginase-1, and IL-
10 in injured muscles (33, 41, 53) and in myeloid cells isolated from injured muscles 
(22, 41), we detected iNOS, TNFα, arginase-1, and IL-10 mRNA in injured muscles at 
both 2 and 5 days after lengthening contractions. Our finding that after 5 days, mRNA 
levels of iNOS and TNFα were elevated in muscles from old mice relative to young 
suggests that rather than an age-related impairment of macrophage function, iNOS and 
TNFα were produced in excess by macrophages in the old mice. In support of this 
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conclusion, macrophages have been identified as a source of TNFα and iNOS after 
muscle injury (22, 41) and in the present study, iNOS and TNFα mRNA levels were 
elevated in muscles of old mice despite fewer macrophages in injured muscles from old 
compared with young mice at this time point. Although low concentrations of TNFα and 
some iNOS expression appear to benefit repair (41, 54), an overproduction of TNFα 
and iNOS can be detrimental. TNFα can inhibit myogenic differentiation in vitro and in 
vivo, lead to the degradation of transcription factors critical for muscle regeneration (55, 
56) and induce muscle protein degradation and apoptosis (54) while iNOS-expressing 
macrophages can injure muscle cells in vitro (57) and in vivo (58). Therefore, excessive 
TNFα or iNOS production by macrophages could undermine or impair muscle 
regeneration in aged animals. Macrophages and specifically anti-inflammatory 
macrophages have been identified as the source of IL-10 after muscle injury (22, 59). 
After 2 days, we found less IL-10 mRNA in muscles of old mice relative to young, in 
spite of more CD163+ cells in old muscles as compared with young at this time point. 
Thus, the age-related decrease in IL-10 mRNA could suggest impaired IL-10 production 
in aged macrophages. Impaired IL-10 production can be detrimental to muscle repair. 
Mice lacking IL-10 show persistent fiber damage and greatly slowed regeneration and 
growth after an unloading/reloading muscle injury (33). IL-10 can contribute to repair by 
several mechanisms. IL-10 stimulated macrophages promote the proliferation and 
differentiation of myogenic precursors in vitro and in vivo (58, 59). IL-10 can also play a 
regulatory role, suppressing the production of pro-inflammatory cytokines IL-1, IL-6 and 
TNFα	   (60), while stimulating production of the growth factor IGF-1 (59). Therefore, 
insufficient IL-10 production by aged macrophages could lead to deficient repair. 
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Overall, our findings suggest age-related changes in the expression of macrophage-
associated genes, which have the potential to undermine or impair muscle regeneration 
in aged animals.  
An age-related increase in neutrophil and macrophage content in injured muscles 
may also reflect an increased pool of cells available to respond to the injury or an age-
related increase in recruitment signals. The former possibility is supported by our 
observation of elevated levels of circulating neutrophils and monocytes in old compared 
with young mice. While correlation does not necessarily imply causation, the possibility 
exists that more neutrophils and macrophages accumulated in injured muscles of old 
animals relative to young because more neutrophils and monocytes were available to 
respond to recruitment signals by damaged muscle. Recruitment signals for neutrophils 
and monocytes may also be elevated with age. Resident myeloid cells can recruit other 
inflammatory cells to injured muscle (61). In uninjured muscles we observed more 
neutrophils in old mice than in young, a finding that is in agreement with others (51). 
Total macrophages in uninjured muscles were not different between the age groups, 
also in agreement with other reports (5, 51) but more CD163+ cells were observed in 
the present study in muscles from old mice relative to young. These findings suggest 
that muscle displays an age-associated change in the composition of resident myeloid 
cells. Age-related changes in resident cell populations could affect recruitment of 
myeloid cells after muscle injury, but this hypothesis remains to be tested.  
An unexpected finding of the present study was that we found slightly less 
damage in muscles from old mice relative to young. Previous studies using the in situ 
EDL injury model using mice of the same strain, sex, and of similar age have found 
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force deficits that were not different between young and old mice (51, 62) while one 
study found greater force deficits in old mice (63). It may be that the difference we saw 
was due to the specific cohort tested. The old mice in the present study generated less 
absolute force and less specific force than young controls, but significant differences in 
these measures are not always observed (7, 51, 63), suggesting that our cohort showed 
more of an aged phenotype than cohorts from other studies. If activation was somewhat 
impaired in the old mice in the present study due to aging-associated degeneration of 
neuromuscular junctions (64), impaired blood flow (65) or other factors, less damage 
would be expected after lengthening contractions in the old group relative to the young. 
Regardless of which factors contributed to the difference in initial damage between 
groups, normalizing neutrophil and macrophage content to the initial force deficit 
provided a measure of the cellular response to a given amount of damage. 
Our study is not without limitations. We assessed only two measures of 
regeneration, the number and size of regenerating fibers as observed by H&E staining 
of muscle cross-sections. Despite these limited data, age-related impairments in 
regeneration after muscle injury have been firmly established by a variety of studies (1-
10). To examine function of myeloid cells in injured muscle, we examined mRNA levels 
at the tissue level. Therefore, we could not confirm the cellular source of the mRNA and   
altered mRNA levels do not necessarily reflect changes in protein content. Future 
studies could address these limitations by isolating different myeloid cell populations 
from injured muscles of young and old mice and examining mRNA and protein levels of 
purified cells. 
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In summary, our findings indicate that the myeloid cell response to injury was 
altered in old mice relative to young. However, contrary to our hypothesis, the altered 
myeloid cell response was not characterized by a persistence of neutrophils, impaired 
total macrophage accumulation, or a delay in the accumulation of M2 macrophages.  
The results indicated an enhanced response in the magnitude of neutrophils, total 
macrophages and M2 macrophages to injury in old mice relative to young, perhaps due 
to elevated circulating levels of neutrophils and monocytes in aged mice. In addition to 
the altered magnitude of the myeloid cell response to injury, aged myeloid cells may 
differentially express genes that have implications for muscle repair. Despite the 
impairments in muscle regeneration observed in old animals as well as the 
accumulating evidence that myeloid cells play a critical role in muscle repair following 
injury, the effect of aging on the magnitude and the timing of the myeloid cell response 
has received little attention. This study addresses gaps in our knowledge of aging-
related changes in the myeloid cell response to injury, including the response of M2 
macrophages, which to our knowledge, have not been examined in aged muscle after 
injury.  
 
Acknowledgements 
 
This work was supported by NIH grants AG-020591 to SVB and AG-000114 to 
DDS. We would like to thank the Unit for Laboratory Animal Medicine (ULAM) Pathology 
Core for Animal Research (PCAR) at the University of Michigan for performing the blood 
cell counts. 
 
 
66	  
 
Figure 3.1: Initial force deficit after lengthening contractions was about 20% less in 
muscles from old mice relative to young (*P = 0.014).    
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Figure 3.2: Damage 2 and 5 days after lengthening contractions in young and old mice. 
Force deficits (A). Force deficits increased between 2 and 5 days (day effect, P = 0.016) 
and were significantly less for muscles of old mice relative to young (age effect, P < 
0.001). There was no significant interaction between day and age (P = 0.151). A similar 
result was found when force deficit was calculated relative to the contralateral muscle 
{Force deficit = [(force of contralateral muscle in vitro – force of injured muscle in vitro) / 
(force of contralateral muscle in vitro)] * 100} (age effect, P = 0.004; day effect, P = 
0.008; interaction, P = 0.231). Injured fibers (B). The percentage of fibers showing signs 
of histological damage increased between 2 and 5 days (day effect, P = 0.008) and 
were significantly less for muscles of old mice relative to young (age effect, P < 0.001). 
There was no significant interaction between day and age (P = 0.151). Total number of 
fibers (C). Two days after lengthening contractions, the total number of fibers was 
unchanged from contralateral control muscles of young and old mice (Table 2) and not 
significantly different between young and old groups (NS, P = 0.446). Five days after 
lengthening contractions, the number of total fibers decreased in young and old 
muscles, indicating that some fibers had completely degenerated (#P < 0.001). The 
number of total fibers was greater in muscles from old mice relative to young at this time 
point (*P = 0.039). Representative partial sections of muscles from young mice (D, F, H) 
and old mice (E, G, I) stained with H&E. Sections are from contralateral muscles (D, E), 
muscles 2 days after lengthening contractions (F, G) and muscles 5 days after 
lengthening contractions (H, I). Scale bar = 200 µm and applies to all images. 
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Figure 3.3: Regenerating fibers in injured muscle from young and old mice, 5 days after 
lengthening contractions. Number of regenerating fibers per muscle cross-section (A). 
While there were fewer regenerating fibers in muscle sections from old mice relative to 
young, the difference was not significant (P = 0.197). Average cross-sectional area of 
regenerating fibers (B). Cross-sectional area was significantly less in muscles from old 
mice (*P < 0.001). Representative partial sections of muscles from young (C) and old 
(D) mice showing regenerating fibers. Scale bar = 50 µm and applies to both images. 
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Figure 3.4: Neutrophil content in injured muscles from young and old mice. Neutrophil 
(Gr-1+ cell) content relative to size of tissue section (A). Neutrophil content declined 
between 2 and 5 days (day effect, P = 0.006) and was significantly greater in muscles 
from old mice relative to young (age effect, P < 0.001). Neutrophil content normalized to 
initial damage (i.e. initial force deficit) (B). Neutrophil content relative to initial damage 
declined between 2 and 5 days after lengthening contractions (day effect, P < 0.001) 
and was significantly greater in muscles from old mice relative to young (age effect, P < 
0.001). Representative partial sections of muscles from young mice (C, E, G) and old 
mice (D, F, H) labeled for Gr-1. Sections are from contralateral muscles (C, D), muscles 
2 days after lengthening contractions (E, F) and muscles 5 days after lengthening 
contractions (G, H). Scale bar = 200 µm and applies to all images. 
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Figure 3.5: CD68+ and CD163+ cells co-localize in injured muscles. Partial muscle 
sections labeled for CD68 (red) and CD163 (green) 2 (A, C, E) and 5 (B, D, F) days 
after lengthening contractions. Cells that were CD163+ were also CD68+ (yellow), 
consistent with CD163 labeling a subset of total macrophages (CD68+ cells). 
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Figure 3.6: CD163+ and CD301+ cells co-localize in injured muscles. Partial muscle 
sections labeled for CD163 (green) and CD301 (red) 2 (A, C, E) and 5 (B, D, F) days 
after lengthening contractions. Cells that were CD163+ were also CD301+ (yellow), but 
not all CD301+ cells were CD163+. 
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Figure 3.7: Total macrophage content in injured muscles from young and old mice. 
Total macrophage (CD68+ cell) content relative to size of tissue section (A). 
Macrophage content increased between 2 and 5 days (#P < 0.001) and was 
significantly greater in muscles from old mice relative to young 5 days after lengthening 
contractions (*P < 0.001) but not after 2 days (NS, P = 0.871). Total macrophage 
content normalized to initial damage (i.e. initial force deficit) (B). Macrophage content 
relative to initial damage increased between 2 and 5 days after lengthening contractions 
(day effect, P < 0.001) and was significantly greater in muscles from old mice relative to 
young (age effect, P = 0.003). Representative partial sections of muscles from young 
mice (C, E, G) and old mice (D, F, H) labeled for CD68. Sections are from contralateral 
muscles (C, D), muscles 2 days after lengthening contractions (E, F) and muscles 5 
days after lengthening contractions (G, H). Scale bar = 200 µm and applies to all 
images. 
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Figure 3.8: M2 macrophage content in injured muscles from young and old mice. M2 
macrophage (CD163+ cell) content relative to size of tissue section (A). M2 
macrophage content increased between 2 and 5 days (day effect, P = 0.015) and was 
significantly greater in muscles from old mice relative to young (age effect, P < 0.001). 
M2 macrophage content normalized to initial damage (i.e. initial force deficit) (B). M2 
macrophage content relative to initial damage increased between 2 and 5 days after 
lengthening contractions (day effect, P < 0.001) and was significantly greater in muscles 
from old mice relative to young (age effect, P < 0.001). Representative partial sections 
of muscles from young mice (C, E, G) and old mice (D, F, H) labeled for CD163. 
Sections are from contralateral muscles (C, D), muscles 2 days after lengthening 
contractions (E, F) and muscles 5 days after lengthening contractions (G, H). Scale bar 
= 200 µm and applies to all images. 
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Figure 3.9: Messenger RNA levels of M1 macrophage genes (iNOS, TNFα) and M2 
macrophage genes (Arg1, IL-10) in old injured muscles relative to young 2 and 5 days 
after lengthening contractions. Messenger RNA levels of iNOS (A, B), TNFα (C, D), 
Arg1 (E, F), and IL-10 (G, H) were normalized to β2-microglobulin mRNA. Messenger 
RNA levels of M1 macrophage genes were not different between young and old 
muscles 2 days after lengthening contractions but were increased in old muscles 
relative to young 5 days after lengthening contractions (iNOS: *P = 0.003, TNFα: *P = 
0.014). Messenger RNA levels of Arg1 were not different between young and old 
muscles 2 or 5 days after lengthening contractions, although there was a trend toward 
elevated Arg1 mRNA levels in old muscle relative to young after 5 days (P = 0.083). 
Messenger RNA levels of IL-10 were significantly less in muscles from old mice relative 
to young 2 days after lengthening contractions (*P = 0.013) but not 5 days after 
lengthening contractions. 
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Figure 3.10: Circulating levels of neutrophils and monocytes are elevated in old mice. 
Summary of neutrophil data, *P = 0.008 (A). Summary of monocyte data, *P = 0.016 
(B).   
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Group n 
Body 
weight 
(g) 
Absolute 
force in 
situ 
(mN) 
Absolute 
force in 
vitro 
(mN)† 
Specific 
force in 
vitro 
(mN/mm²)† 
Muscle 
mass 
(mg)	  † 
CSA from 
H&E 
stained 
sections 
(mm²)†	  
Total 
number 
of 
fibers† 
         
Young 18 32.0 ± 0.8 407 ± 8 473 ± 8 250 ± 4 12.0 ± 0.2 1.9 ± 0.1 951 ± 26 
Old 19 32.7 ± 0.6 343 ± 9* 436 ± 13* 232 ± 6* 11.9 ± 0.3 1.6 ± 0.1* 936 ± 23 
 
Table 3.1: Characteristics of young and old groups. †data taken from contralateral 
muscles. *significantly less than young group (P < 0.05). CSA = cross-sectional area. 
Forces are maximum forces generated during isometric tetanic contractions. Two 
samples are missing from young group for CSA from H&E stained sections and for total 
number of fibers. 
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Group n Gr-1+ cells per mm3 tissue 
CD68+ cells per 
mm3 tissue 
CD163+ cells per 
mm3 tissue 
     
Young 18 337 ± 53  13444 ± 465 10130 ± 348 
Old 15 1470 ± 240* 14083 ± 569 12070 ± 421* 
 
Table 3.2: Neutrophils and macrophages in uninjured and contralateral muscles from 
young and old mice. Neutrophil and macrophage content was not significantly different 
in muscles from contralateral muscles from either day and in muscles from uninjured 
mice. Therefore, data shown was pooled from muscles from uninjured mice and from 
contralateral muscles. *significantly different from young, P ≤ 0.001. 
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Chapter 4 
 
Treatment with P/E-selectin blocking antibodies blunts neutrophil accumulation 
after lengthening contractions but does not reduce damage 
 
Abstract 
 
P- and E-selectins are expressed on the surface of endothelial cells and may 
contribute to neutrophil recruitment following injurious lengthening contractions of 
skeletal muscle. Blunting neutrophil, but not macrophage, accumulation after 
lengthening contractions may provide a therapeutic benefit as neutrophils exacerbate 
damage to muscle fibers while macrophages promote repair. In the present study we 
tested the hypothesis that P- and E-selectins contribute to neutrophil, but not 
macrophage, accumulation in muscles after contraction-induced injury and that reducing 
neutrophil accumulation by blocking the selectins would be sufficient to reduce damage 
to muscle fibers. To test our hypothesis, we treated mice with antibodies to block P- and 
E-selectin function and assessed leukocyte accumulation and damage in muscles two 
days after lengthening contractions. Treatment with P/E-selectin blocking antibodies 
reduced neutrophil content by about half in muscles subjected to lengthening 
contractions while macrophage content was reduced by about a third. In spite of the 
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reduction in neutrophil accumulation, we did not detect a decrease in damage two days 
after lengthening contractions, suggesting that the levels of neutrophils in the muscles 
(50% of controls) were sufficient to induce damage. From a therapeutic perspective, the 
implication is that blocking the selectins may not represent a beneficial approach, and 
additional adhesion proteins may need to be targeted to sufficiently reduce neutrophil 
accumulation to provide a benefit. 
 
Introduction 
 
Skeletal muscle injuries are common and have a variety of causes, including 
physical trauma, extreme temperatures, toxin exposure, invasive surgery, 
ischemia/reperfusion and unloading/reloading. Muscles can also be injured by their own 
contractions (i.e. contraction-induced injury), especially during lengthening contractions 
when muscles are stretched while activated. Regardless of the cause, the initial insult is 
followed by degeneration and necrosis of damaged muscle fibers followed by 
regeneration and repair. In the young and healthy, regeneration is typically rapid and 
complete, but advanced age, muscle disease, and severe injury is associated with 
delayed or incomplete repair. Therefore, reducing the degree of damage after injury is a 
worthwhile goal. 
Accompanying the degeneration and necrosis of fibers in injured muscle is the 
accumulation of inflammatory cells in the tissue. Neutrophils increase in the muscle 
within hours to days of the initial injury. Neutrophils can lyse muscle cells in vitro and 
damage membranes in vivo by mechanisms involving reactive oxygen species (1, 2), 
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and preventing neutrophil infiltration after injury reduces force deficits and histological 
damage to muscle fibers (3-6), suggesting that neutrophils contribute to muscle fiber 
damage. Subsequent to the rise in neutrophils, pro-inflammatory macrophages begin to 
accumulate in injured muscle. Pro-inflammatory macrophages are also capable of lysing 
muscle cells in vitro (7). However, in vivo studies suggest that these cells are ultimately 
beneficial to the repair process, as evidenced by observations that reducing the level of 
invading macrophages delays the clearance of necrotic fibers, reduces the number and 
size of regenerating fibers, and increases fibrosis and fat relative to controls (8-11). 
Thus, preventing or blunting the neutrophil response while keeping the macrophage 
response intact may protect the muscle from unnecessary damage without interfering 
with repair, and provide a therapeutic benefit in cases of delayed or incomplete repair.  
Methods explored to reduce neutrophil accumulation consist of systemic 
approaches, such as depleting cells from the circulation (6, 12) or genetically knocking 
out genes for proteins involved in neutrophil migration out of blood vessels (5, 13). 
These are appropriate experimental approaches for proof-of-concept studies but are not 
feasible as therapeutic interventions. One option for targeted therapeutic intervention is 
the administration of a compound to block the endothelial selectins, P- and E-selectin. 
P- and E-selectins are adhesion proteins expressed by activated vascular endothelial 
cells. Once expressed on the luminal surface of blood vessels, the selectins interact 
with corresponding ligands on neutrophils, “capturing” them from the rapidly flowing 
blood stream and enabling slow rolling along the vessel wall. Capture and slow rolling of 
neutrophils are initial steps in a well-characterized cascade that culminates with 
neutrophil migration out of the blood vessel and into the surrounding tissue (14). 
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Genetic knockout of both P- and E-selectin prevents neutrophil infiltration after an 
unloading/reloading injury but keeps macrophage accumulation intact (13) but, the 
degree to which endothelial selectins contribute to neutrophil and macrophage 
accumulation after other types of muscle injury is unknown. Furthermore, whether 
reducing neutrophil accumulation by targeting the endothelial selectins is sufficient to 
reduce damage to muscle fibers after contraction-induced injury has not been 
examined. 
Therefore, in the present study we tested the hypothesis that endothelial 
selectins contribute to neutrophil, but not macrophage, accumulation in muscles after 
contraction-induced injury and that reducing neutrophil accumulation by blocking the 
selectins would be sufficient to reduce damage to muscle fibers after contraction-
induced injury. To test our hypothesis, we subjected extensor digitorum longus (EDL) 
muscles of mice to lengthening contractions in situ and treated the animals with 
antibodies to block binding of neutrophils to P-selectin (RB40.34) and E-selectin (9A9). 
Two days after lengthening contractions, damage was assessed by functional measures 
and by histology, and neutrophil and macrophage accumulation was assessed by 
immunohistochemistry. 
 
Methods 
 
Animals. Male C57BL/6N mice, 3-5 mo of age were purchased from Charles 
River Laboratories and housed in a specific-pathogen-free facility at the University of 
Michigan until experimentation. Between experimental procedures, mice were housed in 
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a separate specific-pathogen-free return room. All animal use procedures were 
approved by the University of Michigan Committee on the Use and Care of Animals 
(UCUCA). 
In situ evaluation of contractile properties. Procedures for in situ evaluation of 
muscle contractile properties were based on previous studies (15, 16). Each mouse was 
anesthetized with 3% isoflurane in oxygen delivered at a rate of 1 L/min. Anesthesia 
was maintained throughout in situ procedures with 2% isoflurane in oxygen and depth of 
anesthesia was confirmed by failure of the mouse to respond to tactile stimuli. 
Ophthalmic ointment was placed on the mouse’s eyes to prevent corneal drying and 
trauma and this was re-administered throughout in situ procedures. The mouse was 
placed on a platform warmed to 37 °C with a circulating water bath. The hind limb fur 
was removed with animal clippers followed by a minimal amount of fur removal cream. 
The skin was disinfected with chlorhexidine and a small incision was made at the ankle 
to expose the distal tendon of the EDL muscle. Another small incision was made distal 
to the knee to expose the peroneal nerve. A secure knot was tied around the tendon 
with 6.0 braided silk suture. The hind limb was immobilized by pinching the knee and 
the foot with small clamps secured to the platform. Using the tails of the silk suture, the 
intact tendon was tied to the lever arm of a servomotor (300C-LR-FP, Aurora Scientific), 
which controlled the length of the muscle and measured the force generated. A 
computer with custom-designed software controlled stimulus pulses, the servomotor, 
and collected and stored force data. The small area of exposed tendon was kept moist 
by frequent administration of sterile saline. The EDL muscle was activated using a 
stimulator (701C, Aurora Scientific) and platinum electrodes placed under the peroneal 
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nerve. A stimulus pulse duration of 0.2 ms was used for all contractions. Stimulation 
current and muscle length were adjusted in order to elicit maximum twitch force. Tetanic 
contractions of 200 ms duration were elicited with trains of pulses and the frequency of 
the pulses was increased until the force plateaued at the maximum isometric force (Po), 
typically at a frequency of 200 Hz. Finally, small adjustments in the ankle position were 
made to elicit maximum isometric tetanic force. The tetanic contractions were spaced 1 
min apart to prevent fatigue. Optimal muscle length (Lo), defined as the muscle length at 
which maximum isometric force is achieved, was measured with calipers using the knee 
to estimate the location of the proximal end of the EDL muscle. Optimal muscle fiber 
length (Lf) was determined by multiplying Lo by the previously determined Lf-to-Lo ratio 
of 0.45 (17). 
In situ lengthening contraction protocol. Following evaluation of contractile 
properties, the EDL muscle was exposed to a protocol of 75 lengthening contractions 
spaced 4 s apart for a total duration of 5 min. Each contraction was 300 ms in duration. 
100 ms after the onset of stimulation, near maximum isometric force was generated and 
a stretch of 20% strain relative to Lf was initiated. Muscles were lengthened at the 
appropriate rate (1 Lf/s) to cause the peak of the stretch to coincide with the end of the 
tetanic stimulation. Ten minutes after the lengthening contraction protocol, the muscle 
was re-lengthened to achieve maximum twitch tension and Po was re-measured. The 
small incisions at the ankle and distal to the knee were closed with 7.0 sterile 
monofilament nylon suture and bathed with povidone-iodine solution, and mice were 
monitored until they recovered from anesthesia. 
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Administration of blocking antibodies. Approximately 1 hour following in situ 
lengthening contractions, antibodies were administered via intraperitoneal injection(s). 
Mice received either tandem injections of rat anti-mouse monoclonal antibodies specific 
for P-selectin (200 µg, clone RB40.34, BD Pharmingen, 553741) and E-selectin (200 
µg, clone 9A9, generously provided by Dr. Klaus Ley, La Jolla Institute for Allergy & 
Immunology) or a single injection of irrelevant isotype control antibodies (400 µg, A110-
1, BD Pharmingen, 559157). Uninjected mice served as an additional control group.  
The blocking function of RB40.34 and 9A9 has been demonstrated in many 
studies in vitro and in vivo. In vitro, both antibodies prevent attachment of myeloid cells 
to their respective selectins (18, 19). In vivo, RB40.34 alone or together with 9A9 
prevents cytokine-induced leukocyte rolling along blood vessel walls and both 
antibodies reduce chemically-induced neutrophil migration into the peritoneal cavity (18-
23). RB40.34 was detected on platelets in the blood 3 hours after a single 
intraperitoneal injection, and platelets with bound RB40.34 were detected up to 7 days 
after injection when a dose of 200 µg was administered (24). Therefore, this dose of 
RB40.34 and 9A9 was used in the present study to provide blocking coverage over the 
time period studied. 
In vitro evaluation of contractile properties. Two days following administration of 
the lengthening contraction protocols, mice were again evaluated for Po. This time point 
was chosen because preliminary experiments suggested the neutrophil content of 
injured muscles was greatest 2 days after administration of the injury protocol used in 
the present study. Procedures for the in vitro evaluation of EDL contractile properties 
have been previously published (17). Each mouse was anesthetized with an 
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intraperitoneal injection of Avertin (tribromoethanol, 250 mg/kg) (chemical components 
from Sigma-Aldrich). After the mouse was unresponsive to a tactile stimulus, the injured 
EDL muscle was isolated from the hindlimb of the mouse. 5-0 silk suture was tied to the 
proximal and distal tendons of the muscle and the muscle was placed into a chamber 
containing Krebs Mammalian Ringer solution composed of (in mM): 137 NaCl, 5 KCl, 2 
CaCl2·2H2O, 1 MgSO4·7H2O, 1 NaH2PO4, 24 NaHCO3, 11 glucose, 0.03 tubocurarine 
chloride. The solution was maintained at 25 °C and bubbled with 95% O2-5% CO2 to 
maintain a pH of 7.4. The proximal tendon was attached to a stationary object and the 
distal tendon was attached to a force transducer (BG-50, Kulite Semiconductor 
Products). Muscles activation was accomplished by electric field stimulation via a high-
power current stimulator (701C, Aurora Scientific) and parallel plate electrodes.  
A computer and custom-designed software controlled stimulus pulses and 
collected and stored force data. Stimulus pulses of 0.2 ms in duration were used for all 
contractions. Stimulation current and the muscle length were adjusted in order to elicit 
maximum twitch force. A digital calipers was used to measure Lo. Muscles were held at 
Lo and tetanic contractions of 300 ms in duration were elicited with trains of pulses. The 
frequency of the pulses was increased until the force plateaued at Po, typically at 
frequencies from 150-200 Hz. The tetanic contractions were spaced 1 min apart to 
prevent fatigue. Optimal muscle fiber length (Lf) was determined as previously 
mentioned. Force deficit was defined as the difference between the Po measured 
immediately prior to lengthening contractions and the Po measured two days after 
lengthening contractions expressed as a percentage of the pre-injury Po. Following 
evaluation of the injured EDL, the contralateral EDL was removed and evaluated as 
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described. Muscles were trimmed of their tendons and weighed. Muscles were then 
immersed in Tissue Freezing Medium (Electron Microscopy Sciences) and frozen in 
isopentane cooled by liquid nitrogen. The mouse was euthanized with an overdose of 
Avertin followed by induction of a bilateral pneumothorax. 
Histology and immunohistochemistry. EDL muscles were cut into 10 µm thick 
sections on a cryostat. The sections were fixed in cold acetone and stained with 
Hematoxylin (Ricca Chemical Company) and Eosin Y (EMD Millipore). Stained sections 
were imaged with a Nikon E-800 light microscope. The number of injured fibers was 
counted per section and expressed as a percentage of the total number of fibers. 
Injured fibers included those with a swollen appearance, pale or variable staining, and 
obvious infiltration of inflammatory cells (16). 
Muscle sections were analyzed for neutrophil and macrophage content using 
immunohistochemistry. Sections were fixed in cold acetone and air-dried. Sections were 
exposed to BLOXALL solution to block endogenous peroxidase activity followed by 10% 
normal rabbit serum in PBS (Phosphate Buffer Solution, Fisher Scientific) to block non-
specific binding of subsequent antibodies. Neutrophils were detected with a rat anti-
mouse Gr-1 antibody (clone RB6-8C5, 1:50 dilution, BD Pharmingen, 550291) and 
macrophages were detected with a rat anti-mouse CD68 antibody (clone FA-11, 1:1000, 
AbD Serotec, MCA1957) diluted in PBS containing 10% rabbit serum. After incubation 
in primary antibodies, sections were exposed to biotinylated mouse adsorbed anti-rat 
IgG in PBS containing 10% rabbit serum. Following exposure to the secondary 
antibodies, the sections were treated with the VECTASTAIN Elite ABC reagent 
containing peroxidase followed by the peroxidase substrate 3, 3’-diaminobenzidine 
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(ImmPACT DAB). The sections were rinsed with PBS after each step except after the 
treatment with rabbit serum. All reagents were from Vector Laboratories unless stated 
otherwise. In the periphery, neutrophils express high levels of Gr-1 while monocytes 
express low or no levels of Gr-1 (25). Therefore, dark brown cells indicating high levels 
of Gr-1 were counted as neutrophils while the occasional light brown cell of similar size 
was not counted. CD68 is expressed on macrophages and labels early-invading 
macrophages that accumulate in injured skeletal muscle (26-28). An image analysis 
program (Image J) was used to count the number of neutrophils (Gr-1+ cells) or 
macrophages (CD68+ cells) in one transverse section from the middle of each muscle. 
The same program was used to calculate the area of each section and neutrophil or 
macrophage content was expressed per mm3 of muscle.  
The location of neutrophils relative to blood vessels was also analyzed using 
immunohistochemistry. Neutrophils were labeled first according to the methods 
described in the preceding paragraph, except that the normal rabbit serum was 
replaced with Carbo-Free Blocking Solution. Carbo-Free Blocking Solution does not 
contain glycoproteins, which can interfere with subsequent lectin-based detection. To 
label blood vessels, muscle sections were first treated with solutions from an 
Avidin/Biotin Blocking Kit to block endogenous avidin and biotin. Sections were 
incubated in Carbo-Free Blocking Solution to block non-specific binding of the lectin. 
The sections were then treated with a biotinylated Griffonia (Bandeiraea) Simplicifolia 
Lectin I (GSL I, 10 µg/ml in PBS). GSL I labels all blood vessels in skeletal muscle (29). 
The biotinylated lectin was detected by exposing sections to a VECTASTAIN Elite ABC 
reagent containing peroxidase followed by a peroxidase substrate (ImmPACT SG). The 
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sections were rinsed with PBS containing 0.05% Tween 20 (Sigma-Aldrich) following 
the lectin and ABC reagent steps. All reagents were from Vector Laboratories unless 
stated otherwise. The number of neutrophils detected within blood vessels was counted 
and expressed as a percentage of total neutrophils per section. This sequential labeling 
technique may not detect neutrophils within capillaries but within larger vessels only. 
Blood analysis. Blood was collected via a scalpel nick of the lateral tail vein (50-
100 µl per day). Whole blood was analyzed with a cell counter (Hemavet 950FS, Drew 
Scientific) to determine circulating white blood cell counts.  
Statistics.  Data are expressed as means ± 1 SEM. Experimental groups were 
compared with a Student’s t-test unless otherwise indicated, with significance set a 
priori at P < 0.05.    
 
Results  
 
There were no differences among the experimental groups for body weight, 
maximum force generation by the EDL muscle prior to lengthening contractions, or force 
deficit 10 min after the lengthening contractions (Table 4.1). Injecting the irrelevant 
control antibody A110-1 had no significant effect on any of the variables measured 
(selected variables shown in Figure 4.1). Therefore, the A110-1 injected group was 
pooled with the uninjected group to make one “control” group. 
As hypothesized, treatment with P/E-selectin blocking antibodies reduced 
neutrophil content by about half in muscles subjected to lengthening contractions 
(Figure 4.2A). To assess whether the neutrophils that were present in spite of blocking 
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antibody treatment had indeed migrated out of the circulation, we examined neutrophil 
localization relative to blood vessels (Figures 4.2D-4.2E). Irrespective of the 
experimental group, only about 5% of neutrophils were clearly inside blood vessels 
(control: 6 ± 1% vs. anti-P/E-sel: 5 ± 2%), suggesting that most of the neutrophils we 
detected were extravascular. Contrary to our hypothesis, the decrease in neutrophil 
content was not associated with a decrease in damage as assessed by force deficit, 
which was approximately 50% for muscles of both treated and control mice (Figure 4.3). 
Muscles of both groups also showed similar numbers of injured fibers, with 10% to 15% 
of the fibers in a cross section showing morphological evidence of injury (Figure 4.4A). 
Although the number of injured fibers was not different among experimental groups, the 
characteristics of the injured fibers were different (Figure 4.4E), with fewer fibers 
showing signs of inflammatory cell infiltration and more fibers with variable or pale 
staining in the muscles from mice injected with blocking antibodies. Also contrary to our 
hypothesis was the observation that macrophage content showed a trend (P = 0.076) 
toward a reduction by approximately one-third in muscles of treated compared with 
control mice.  
An unexpected finding was an effect of treatment with P/E-selectin blocking 
antibodies on the contralateral muscles that were not subject to lengthening 
contractions (Figure 4.6). Although force generation of contralateral control muscles 
was not affected by the treatment with the selectin blocking antibodies (control: 258 ± 5 
mN/mm2 vs. anti-P/E-sel: 248 ± 6 mN/mm2) nor was there any morphological evidence 
of injured fibers (control: 0.13 ± 0.07% vs. anti-P/E-sel: 0.23 ± 0.10%), neutrophil 
content was increased by more than 4-fold (Figure 4.6A). Thirteen percent of these 
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neutrophils were found within blood vessels, compared with 33% in control muscle 
sections (control: 33 ± 8% vs. anti-P/E-sel: 13 ± 5%, t-test, P = 0.089), suggesting that 
the majority of the neutrophils in the contralateral muscles were also extravascular. 
Blood analysis revealed that the blocking antibody treatment dramatically increased 
circulating neutrophils (Figure 4.7A) that may have driven neutrophils into contralateral 
muscles in the absence of lengthening contractions, as well as contributing to the 
increased neutrophil levels in injured muscles. Although neutrophils were elevated in 
contralateral muscles of treated mice the levels did not reach those observed in injured 
muscles from mice treated with P/E-selectin blocking antibodies (contralateral: 1210 ± 
159 Gr-1+ cells / mm3 tissue vs. injured: 2624 ± 530 Gr-1+ cells / mm3 tissue, t-test, P = 
0.045). Treatment with P/E-selectin blocking antibodies also increased circulating 
monocytes (Figure 4.7B), although the difference was less dramatic than for neutrophils 
and did not reach significance (effect of blocking antibody treatment, P = 0.066). The 
trend toward elevated numbers of circulating monocytes was not associated with 
increased macrophage content in contralateral muscles (Figure 4.6D).  
 
Discussion 
 
The major implication of the present study is that endothelial selectins (P- and/or 
E-selectin) contribute to, but are not necessary for, neutrophil accumulation after 
contraction-induced injury. Support for this conclusion is provided by our observation 
that treating animals with blocking antibodies for P- and E-selectin reduced but did not 
eliminate neutrophils in sections of injured muscles. Our results also indicate that 
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reducing neutrophil accumulation to approximately 50% of control levels is not sufficient 
to reduce damage after contraction-induced injury, as evidenced by the observations 
that the treatment and accompanying blunted accumulation of neutrophils did not result 
in a reduction of the force deficit or the number of fibers showing histological evidence 
of damage. Our study was not decisive on the question of whether or not blocking the 
endothelial selectins left macrophage accumulation intact. Muscles of mice treated with 
blocking antibodies showed two thirds as many macrophages following lengthening 
contractions compared with the numbers observed in untreated mice, but the decrease 
did not reach reach statistical signifcance. Therefore, the remainder of the discussion 
will focus primarily on neutrophils. 
The finding that endothelial selectins contribute to neutrophil accumulation after 
contraction-induced injury was not known but was expected. Many studies have 
demonstrated a role for the selectins in leukocyte capture and rolling along blood vessel 
walls in the cremaster muscle (20-23, 30). In addition, neutrophil accumulation in soleus 
muscle after unloading followed by reloading was reduced in mice deficient in P- and E-
selectin, suggesting that the endothelial sections contribute to neutrophil accumulation 
in this injury model (13). Despite these previous investigations of selectin function in 
skeletal muscle, neutrophils can accumulate in tissues using adhesion molecules other 
than P- and E-selectin (see discussion in following paragraph), and the involvement of 
endothelial selectins in neutrophil accumulation following contractions-induced injury 
had not been demonstrated prior to the present study. 
While our results indicate that P- and/or E-selectin contribute to neutrophil 
accumulation after contraction-induced injury, our observation that neutrophil content 
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was not completely eliminated in injured muscles after treatment with blocking 
antibodies suggests that selectins are not necessary for neutrophil accumulation in this 
model. In the absence of P- and E-selectin function, other adhesion molecules such as 
L-selectin or vascular cell adhesion molecule 1 (VCAM-1) may contribute to neutrophil 
accumulation. L-selectin expressed on free flowing leukocytes can interact with PSGL-1 
on rolling or adherent leukocytes in a process known as secondary capture, and the 
proportion of captured cells seized by this mechanism increases after P-selectin is 
blocked or absent (23). Furthermore, in cremaster or gracilis pedicle muscle, leukocyte 
rolling and neutrophil migration out of the vasculature is impaired when L-selectin is 
blocked or deficient (31-33). VCAM-1 expressed on endothelial cells can interact with α4 
integrins on leukocytes, and residual leukocyte rolling after blocking P- and E-selectin or 
in mice lacking all three selectins was further reduced with blocking antibodies to either 
VCAM-1 or α4 integrin (23, 30). Therefore, neutrophil rolling mediated by VCAM-1 and 
α4 integrin followed by secondary capture mediated by L-selectin and PSGL-1 may 
have contributed to the neutrophil accumulation in injured muscles observed in the 
present study. We also cannot rule out the possibility that P- and E-selectin are, in fact, 
required for neutrophil accumulation but that the amount of RB40.34 and 9A9 injected in 
the present study (200 µg for each antibody) was insufficient to completely block P- and 
E-selectin function. While we have no independent measure of selectin function to allow 
assessment of the effectiveness of our blocking treatment, 200 µg of RB40.34 almost 
completely eliminated macrophage migration out of injured arteries, suggesting that the 
dose of at least RB40.34 was sufficient for close to complete blockage (24). 
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Our finding that treatment with blocking antibodies reduced neutrophil 
accumulation in injured muscles but did not reduce damage is compatible with existing 
studies. Several studies examining damage after lengthening contractions found that 
effectively preventing neutrophil accumulation to a great extent (80-90% reduction in 
neutrophils) reduced force deficit and histological damage after injury caused by 
lengthening contractions, with specific reductions in damage ranging from 
approximately 30% to 80% (4-6). However, a reduction in damage by neutrophil 
depletion is not a universal finding. In one study, >90% of circulating neutrophils were 
depleted with antisera prior to lengthening contractions of hindlimb muscles, yet no 
reduction in force deficit or in the quantity of injured fibers relative to controls was 
observed (12). Nevertheless, the majority of studies to date suggest that the damage 
after lengthening contractions is at least in part mediated by neutrophils. In light of these 
studies, the most defensible interpretation of our findings is that the residual neutrophil 
accumulation in the presence of blocking antibody treatment, about 50% of control 
levels, was sufficient to induce neutrophil-mediated damage in injured muscles. 
While the blocking antibody treatment did not affect the total number of injured 
fibers, the characteristics of injured fibers were different (Figure 4.4E). Increased 
intracellular calcium after muscle injuries can cause hypercontractions of portions of 
muscle fibers and leave adjacent portions of the same fibers barely visible or missing 
(34, 35). Thus, dark, swollen fibers (Category 1) or fibers with variable staining 
(Category 2) could represent portions of fibers that were hypercontracted. Pale fibers 
(Category 2) could represent segments of fibers that were adjacent to hypercontracted 
regions or fibers containing degraded contractile proteins, perhaps as a result of 
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calcium-sensitive proteases (36). Data from a parallel experiment using untreated mice 
showed that 5 days after lengthening contractions, the number of Category 1 and 2 
fibers declined while the number of Category 3 fibers increased (data not shown), 
suggesting that over the course of the degenerative stage of repair, fibers show signs of 
damage and degeneration and are subsequently invaded by inflammatory cells. Thus, 
an interpretation of Figure 4.4E is that the blocking antibody treatment did not affect the 
number of fibers showing signs of degeneration or necrosis, but decreased the number 
of degenerating or necrotic fibers that had subsequently been invaded by inflammatory 
cells. This finding could be explained by decreased neutrophil accumulation with 
antibody treatment, or it could be explained by the reduced macrophage accumulation 
with antibody treatment, as macrophages are frequently found within degenerating 
fibers 2 days after injury. Both neutrophils and macrophages are thought to participate 
in the removal of necrotic tissue after injury. Teixeira et al. 2003 depleted neutrophils 
prior to toxin-induced muscle injury and observed delayed clearance of necrotic fibers 
accompanied by fewer regenerating fibers and fibrosis. However, the impaired 
regeneration could have been due to the decrease in macrophage accumulation that 
was also observed (37) as other studies that have depleted only macrophages prior to 
muscle injury have found similar impairments in regeneration (8, 9). We did not examine 
whether the reduced neutrophil accumulation observed in the present study ultimately 
had an impact on the removal of necrotic tissue or on regeneration and repair, but this is 
an important consideration for future studies.  
Although our study was not decisive on the question of whether or not blocking 
the endothelial selectins left macrophage accumulation completely intact, we can say 
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that macrophage accumulation was not dramatically altered with P- and E-selectin 
blocking antibody treatment. This conclusion is consistent with a previous report that 
treatment with RB40.34 did not reduce accumulation of CD11b+ cells after lengthening 
contractions in mouse soleus muscles (38). Although CD11b is present on neutrophils, 
monocytes, and macrophages, the authors report very few neutrophils in their study. 
Therefore, their finding suggests that monocyte/macrophage accumulation is not 
dependent upon P-selectin, with the caveat that they may have not seen an effect due 
to the small concentration of RB40.34 injected (20 µg) or the targeting of only one 
selectin. Another report found that macrophage accumulation after unloading and 
reloading of mouse soleus muscle was not affected in P/E-selectin deficient mice (13). 
Overall, the data from the previous studies as well as the present study suggests that 
macrophages accumulate in injured skeletal muscle predominantly by P/E-selectin 
independent mechanisms. The trend toward decreased macrophage accumulation 
observed in the present study could be due to the decrease in neutrophil accumulation, 
as macrophage recruitment is one proposed role for neutrophils after muscle injury (37). 
We were surprised by the observation that treatment with P- and E-selectin 
blocking antibodies increased neutrophil content in the contralateral muscles that were 
not subject to lengthening contractions. Blood analysis showed that treatment with 
blocking antibodies after injury dramatically increased the level of circulating 
neutrophils. The latter finding is consistent with other reports also showing elevated 
levels of circulating neutrophils in selectin deficient mice or in mice treated with blocking 
antibodies for P- and E-selectin (13, 19, 39), and may reflect the displacement of 
marginated neutrophils from blood vessel walls. Therefore, the dramatic increase in 
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circulating neutrophils observed in the present study may have driven more neutrophils 
into the contralateral muscles and presumably into the injured muscles, as well. We did 
not see more macrophages in the contralateral muscles, perhaps because there was 
only a trend for an increase in circulating levels of monocytes. Despite the substantial 
increase in neutrophil content in the contralateral muscles, we saw no evidence that the 
presence of the neutrophils in the tissue had any damaging effects on the muscle as 
assessed by the maintenance of force generating capability and also by the lack of 
histological evidence of injury. The uncoupling between neutrophil accumulation and 
muscle injury implies that merely the presence of neutrophils is not sufficient to induce 
damage. Additional factors such as neutrophil transcriptional activity, degranulation or 
reactive oxygen species production, perhaps induced by the injured tissue environment, 
may be responsible for neutrophil-mediated exacerbation of damage to muscle fibers. 
In summary, the present study provides evidence that endothelial selectins (P- 
and/or E-selectin) contribute to neutrophil accumulation after contraction-induced injury, 
while macrophage accumulation appears to occur by mostly endothelial selectin-
independent mechanisms. In spite of the reduction in neutrophil accumulation, we did 
not detect a decrease in damage two days after lengthening contractions, suggesting 
that the levels of neutrophils in the muscles (50% of controls) were sufficient to induce 
damage. From a therapeutic perspective, the implication is that blocking the selectins 
may not represent a beneficial approach. Additional adhesion proteins may have to be 
targeted to fully prevent neutrophil accumulation.  An alternative approach would be to 
target specific functions of neutrophils that exacerbate damage. Determining the effect 
of these approaches on later stages of the repair process is also an important area of 
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investigation. Therapies targeting adhesion molecules or specific functions of 
neutrophils will also have to consider the effect on the muscle at later stages of the 
repair process. 
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Figure 4.1: Injection of irrelevant control antibody A110-1 has no significant effect on 
damage or inflammatory cells in muscles 2 days after lengthening contractions. Force 
deficit (A). Injured fibers (B). Neutrophils (Gr-1+ cells) (C). Macrophages (CD68+ cells) 
(D).  
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Figure 4.2: Treatment with blocking antibodies against P/E-selectin decreases 
neutrophil content in muscles 2 days after lengthening contractions. Neutrophils (Gr-1+ 
cells) ∗P = 0.005 by Mann-Whitney Rank Sum Test (A). Representative partial section 
of muscle from uninjected mouse (B) and mouse injected with blocking antibodies (C) 
with scale bars = 200 µm. Examples of neutrophil (Gr-1+ cells, brown) and blood vessel 
(GSL I, gray) co-labeling with scale bars = 50 µm (D, E). Neutrophils outside of vessels 
(D). Neutrophils on the inner surface of large vessels (E).    
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Figure 4.3: Treatment with blocking antibodies against P/E-selectin does not 
significantly decrease muscle damage 2 days after lengthening contractions, as 
assessed by force deficit.  
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Figure 4.4: Treatment with blocking antibodies does not reduce the total number of 
injured fibers but reduces the percentage of injured fibers that are invaded by 
inflammatory cells, 2 days after lengthening contractions. Total injured fibers expressed 
as a percentage of the total number of fibers in a muscle section (A). Representative 
partial section of muscle from uninjured mouse (B), uninjected mouse (C), and mouse 
injected with P/E-selectin blocking antibodies (D). Injured fibers expressed as a 
percentage of the total number of injured fibers in a muscle section (E). Injured fibers 
fell into one of three categories. Category 1 consisted of round and often swollen fibers 
stained dark with eosin Y. Category 2 consisted of fibers with variable or pale staining 
with eosin Y. Category 3 consisted of fibers similar to those in category 2 but with 
several nuclei within the fiber, assumed to be inflammatory cells. ∗significantly different 
from category 1 within experimental group. #significantly different from category 2 within 
experimental group. ψsignificantly different from control within category. Significance 
was determined by a Two Way ANOVA (P < 0.05) (E). Magnified views of fibers from C 
and D (F - I). Examples of category 1 (F), category 2 (G, H) and category 3 (I) fibers. 
Scale bars = 200 µm.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
114	  
 
 
Figure 4.5: Treatment with blocking antibodies against P/E-selectin decreases 
macrophage content in muscles 2 days after lengthening contractions, although the 
decrease is not statistically significant (P = 0.076 by Mann Whitney Rank Sum Test). 
Macrophages (CD68+ cells) (A). Representative section of muscle from uninjected 
mouse (B) and mouse injected with blocking antibodies (C). Scale bars = 200 µm.  
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Figure 4.6: Treatment with blocking antibodies against P/E-selectin increases 
neutrophil but not macrophage content after 2 days, in contralateral muscles that have 
not been subjected to lengthening contractions. Neutrophils (Gr-1+ cells) (A). 
Representative partial section of muscle from uninjured mouse (B) and mouse injected 
with P/E-selectin blocking antibodies (C), Gr-1 labeled. Macrophages (CD68+ cells) (D). 
Representative partial section of muscle from uninjured mouse (E) and mouse injected 
with P/E-selectin blocking antibodies (F), CD68 labeled. Scale bars = 200 µm.  
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Figure 4.7: Circulating levels of major populations of white blood cells before and after 
lengthening contractions. Note that injection of blocking antibodies occurred within an 
hour of lengthening contractions. Neutrophils increased significantly with blocking 
antibody treatment ∗significantly different from control, #significantly different from 1 d 
pre-LC value ψsignificantly different from 1 d post-LC value (A). Monocytes increased 
with blocking antibody treatment but the increase did not reach significance (P = 0.066) 
(B). Lymphocytes increased 2 days after lengthening contractions in both experimental 
groups # significantly different from 1 d pre-LC value (C). Data was analyzed by a Two 
Way Repeated Measures ANOVA (significance set at P < 0.05).  
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Group 
Sample 
size 
Body 
weight (g) 
Isometric force 
in situ (mN) 
Immediate 
force deficit 
(%) 
     
Uninjected 10 30.0 ± 0.6 414 ± 12 52 ± 3 
A110-1 injected 3 31.3 ± 1.4 411 ± 2 48 ± 6 
RB40.34/9A9 injected 8 29.1 ± 0.5 395 ± 7 52 ± 4 
 
Table 4.1: Summary of data collected from experimental groups prior to antibody 
injections. Body weight, initial force generation of EDL muscles, and immediate force 
deficit after lengthening contractions were not different among experimental groups. 
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Chapter 5 
 
Conclusions and future work  
 
Summary of objectives 
 
Aging is associated with progressive declines in skeletal muscle mass and 
function that can significantly impact quality of life and limit independence in older 
individuals. Muscles of aged individuals are more susceptible to damage and have a 
diminished ability for repair. Thus, cycles of injury and incomplete recovery may occur 
and contribute to progressive declines in muscle function. Therefore, finding ways to 
restrict damage after muscle injury and/or enhance repair is a worthwhile goal for the 
benefit of older individuals. Developing strategies to restrict damage or enhance repair 
for older individuals requires a mechanistic understanding of both the damage and 
repair processes following injury and the impact of aging on those processes. The 
overall objective of this dissertation was to address fundamental gaps in our knowledge 
of cellular and molecular events associated with a common form of muscle injury and to 
identify age-related changes in key events. The specific goals were to 1) determine the 
role of ROS in initiating lengthening contraction-induced injury, 2) to determine the 
contribution of alterations in the myeloid cell response to injury and/or 
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regeneration in adult and old mice, and 3) to determine the role of P- and E-selectin in 
neutrophil accumulation following lengthening contraction-induced injury.  
 
Summary of conclusions 
 
The primary conclusions of this dissertation are briefly summarized below: 
 
In vitro experiments in mouse lumbrical muscles revealed that lengthening 
contractions that damaged the muscle did not generate more ROS than isometric 
contractions that did not cause damage. This study argues against an increase in ROS 
in skeletal muscle fibers as an initiating factor in degenerative and regenerative 
processes occurring following the initial injury and does not provide support for 
antioxidant interventions early on in the injury process (Chapter 2). 
In situ experiments using mouse EDL muscles revealed that impaired 
regeneration in muscles from old mice was accompanied by an altered neutrophil 
response to injury (Chapter 3). The altered response was not characterized by a 
persistence of neutrophils. Rather, neutrophils were elevated in injured muscles of old 
mice relative to young. Neutrophils can exacerbate damage to injured muscle fibers and 
therefore, an age-related elevation in neutrophils could further exacerbate damage to 
injured muscles beyond levels in young mice and thus undermine repair. Experiments 
described in Chapter 4 provided insight regarding this possibility. Treating mice with 
blocking antibodies for P/E-selectin after lengthening contractions decreased neutrophil 
accumulation by half but did not reduce damage, suggesting that only a portion of 
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accumulating neutrophils are sufficient to exacerbate damage (Chapter 4). Therefore, 
we conclude that modest changes in neutrophil content does not affect damage to 
muscle fibers after lengthening contractions. We speculate that the age-related increase 
in neutrophil content did not further exacerbate damage to injured muscles beyond 
levels in young mice.  
In situ experiments using mouse EDL muscles also revealed that impaired 
regeneration in muscles from old mice was accompanied by an altered macrophage 
response to injury (Chapter 3). The altered response was not characterized by a delay 
or reduction in the accumulation of total or M2 macrophages. Instead, macrophage 
accumulation was generally elevated in injured muscles of old mice relative to young.  
Gene expression data revealed age-related changes in the expression of macrophage-
associated genes that have the potential to undermine or impair muscle regeneration. 
Thus, we propose the mechanism underlying age-related susceptibility to damage 
and/or deficient repair may include altered function of aged macrophages.  
In situ experiments using mouse EDL muscles revealed that endothelial selectins 
(P and/or E-selectin) contributed to neutrophil accumulation after lengthening 
contractions. However, blocking the endothelial selectins did not completely prevent 
neutrophil accumulation, and we did not detect a decrease in damage two days after 
lengthening contractions. We conclude that blocking only the selectins may not provide 
a therapeutic benefit, and that additional adhesion proteins may have to be targeted to 
fully prevent neutrophil accumulation and reduce damage after lengthening contractions 
(Chapter 4).  
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Future work 
 
The most exciting findings described in this dissertation were the age-related 
differences in the myeloid cell response to muscle injury, and the indication that myeloid 
cells from aged mice exhibit altered function that could influence the repair process. 
These findings provide direction for future studies that will ultimately be aimed at 
manipulating pathways to reduce injury or enhance repair. 
Further work should be done to clarify and further characterize the effects of 
aging on myeloid cell function. Because we examined mRNA at the tissue level, we 
could not confirm the cellular source of the mRNA and we did not assess changes in 
protein content. Future studies could isolate different myeloid cell populations 
(neutrophils and macrophages) from injured muscles of young and old mice via cell 
sorting methods (1) and examine mRNA and protein levels of purified cells. Enzyme 
activity could also be examined (e.g. arginase-1 or iNOS activity in macrophages and 
myeloperoxidase or elastase activity in neutrophils). In addition to the production of 
cytokines and molecules, other aspects of myeloid cell function could also be examined. 
For example, phagocytosis could be assessed by quantifying muscle protein in purified 
populations of myeloid cells, or by in vitro assays (1).  
Once the effects of aging on myeloid cell function were clarified and further 
characterized, identified targets could be manipulated in young and/or old mice and the 
effects on muscle injury and/or repair could be assessed. Mice that are genetically 
engineered to either lack expression or conversely, overexpress certain genes in 
myeloid cells could be used for experiments. Alternatively, levels of certain molecules 
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(e.g. IL-10) could be restored at different time points by injection to injured muscles of 
wild-type mice. Ultimately, promising targets identified from these studies could be 
manipulated to reduce injury or enhance repair in old animals.    
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